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ABSTRACT !
Due to the high prevalence of obesity in America (around 35%) and in Europe 
(above 20%) and its dramatic consequences on human health, research aiming 
to understand the basic mechanisms that regulate food intake, appetite and body 
weight is therefore needed. 
New evidences suggest that fuel sensing occurs in a number of peripheral cell 
types, which include specific taste receptors in the gut. These receptors produce 
a chemical cascade signaling the central nervous system (CNS) for energy 
balance regulation. At the same time in the CNS specific brain regions directly 
sense fuel status. An emerging new methodology investigates neural correlates 
of appetite and satiety, using functional neuroimaging techniques. 
In the present work we aim at investigating the brain-gut matrix. First, through a 
systematic review of the literature, previous studies assessing the effects of 
nutrients on brain functions were examined to identify a common research 
methodology and related results. 
Afterwards we extensively study the effects of sugars and amino acids on the 
food-reward system, focusing on brain resting state functional connectivity. 
Finally, we focus on glucose and fructose effects on cognitive functions, by 
investigating two of the most common dimensions of cognitive functions such as 
working memory and response inhibition.  
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INTRODUCTION 
 
 
The prevalence of obesity in America is around 35% (Kivimäki et al, 2017) and 
above 20% in the most populated European countries (Blundell et al, 2017). 
Overweight leads to dramatic health consequences (Hruby and Hu, 2015). 
Research aiming to understand the basic mechanisms that regulate food intake, 
appetite and body weight is therefore needed. 
 
New evidences suggest that fuel sensing occurs in a number of peripheral cell 
types, which include specific taste receptors in the gut (Roper and Chaudhari, 
2017). These receptors produce a chemical cascade signaling the central 
nervous system (CNS) for energy balance regulation (Roper and Chaudhari, 
2017). At the same time in the CNS specific brain regions directly sense fuel 
status. There is ample evidence that links levels of glucose to specific 
populations of neurons in the CNS that are likely to modulate appetite and 
energy balance (Page et al, 2013). Therefore it is nowadays clear that nutrient-
activated gut-to-brain signaling pathways play a major role in the control of 
digestive function, appetite and energy intake. Specifically, the release of a 
number of signaling peptides from nutrient sensing enteroendocrine cells (EEC), 
including glucagon-like peptide-1 (GLP-1) and cholecystokinin (CCK) signal, the 
central nervous system (CNS) to the brainstem and hypothalamus, via both the 
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vagus nerve and the bloodstream, regulating the food-reward networks and 
regulating satiety and appetite (Chaudhri et al, 2008).  
Pharmaco-Imaging of nutrients intake. 
Every time we eat, nutrients trigger different peptides in our gut, which influence 
various systems in our body, including the central nervous system (CNS) 
(Cummings and Overduin, 2007). In parallel, the brain regulates our eating 
behavior by modulating activations in brain regions controlling appetite, food-
reward and body weight (Ahima and Antwi, 2008).  
As stated above, neuroscience began to consider these brain–gut interactions as 
an inter-dependent system, developing a research line aiming at depicting the 
effects of different nutrients on specific brain areas, which subsequently influence 
our (eating) behavior (Page et al, 2013).  
 
Functional brain imaging techniques have greatly facilitated the investigation of 
the human brain–gut interaction in the last decades. The effects of nutrients 
ingestion on the human brain can now be studied by combining the BOLD signal 
variation (Blood oxygen level dependent, an indirect marker of neuronal 
activation) together with the measurement of hormones plasma concentration 
(Aziz, 2012). A pioneering study of Liu (Liu et al, 2000a) integrated hormones 
plasma analyses and Magnetic Resonance Imaging (MRI) examination, 
demonstrating for the first time a direct link between glucose administration, 
insulin and glucose plasma level modification and BOLD changes in the 
hypothalamus and the cingulate cortex. These findings suggest that functional 
 8 
MRI (fMRI) can depict the effects of nutrients administration to the functional 
activity of human brain regions involved in appetite and food-reward pathways.  
 
After the first attempt by Liu (Liu et al, 2000a), subsequent neuroimaging studies 
on the brain-gut matrix reported discrepancies in the methodology (Sizonenko et 
al, 2013). This is mainly due to the different nutrients ingested and to the different 
paradigms used during fMRI examination. A general overview of the brain-gut 
literature and of the methodologies used in the field is therefore necessary. 
 
The impact of sugars ingestion on brain functions. 
Nutrients ingestion is essential for survival and implies the capacity to adjust food 
intake in response to changing energy requirements due to environmental 
demanding tasks (Morton et al, 2006). This homeostatic control is regulated by a 
deep interconnection between cellular, neuronal and behavioural mechanisms 
that link changes of body fat stores and adaptive adjustments of feeding 
behaviour to finally comply adaptive tasks.  
 
Sugars operate an important role in metabolic processes and changes were 
reported at the neural level after their ingestion (Liu et al, 2000b).  Glucose and 
fructose, two of the most investigated monosaccharides, have a roughly equal 
number of calories but are metabolized differently (Luo et al, 2015). While 
glucose stimulates the secretion of insulin, a hormone that signals the brain to 
increase satiety and to blunt the reward value of food (Figlewicz and Benoit, 
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2009; Woods et al, 1998), fructose is associated to insulin resistance (Aeberli et 
al, 2013). Beside the cellular level, the different metabolism of fructose and 
glucose may explain also their differential effects on neuronal pathways. As a 
milestone study of Page has documented (Page et al, 2013) investigating neural 
correlates of appetite, changes in regional cerebral blood flow and increase in 
functional connectivity after glucose ingestion can be highlighted in regions as 
the hypothalamus, insula, anterior cingulate, and striatum (appetite and reward 
regions). Fructose is demonstrated to reduce relative cerebral blood flow (rCBF) 
and increase functional connectivity in the posterior cingulate cortex, and visual 
cortex. Ingestion of glucose compared to fructose resulted in a reduction in 
hypothalamic cerebral blood flow (Luo et al, 2015).  
 
Moreover, sugars may also affect brain areas activations involved in complex 
tasks, as cognitive functions. This is suggested by behavioural results previously 
documented in studies on humans and animals (Martin and Benton, 1999; 
Stollery and Christian, 2016; Woodie and Blythe, 2017). Between the different 
adaptive skills of the human being, in fact, cognitive functions are essential to 
process the information coming from the reality, requiring resources to support 
different levels of complex task performance (Kondraske, 2010). They include 
several domains as attention, working memory and decision-making (Alhola and 
Polo-Kantola, 2007). While nutrients ingestion can impact our cognitive functions 
(le Coutre and Schmitt, 2008; Gomez-Pinilla and Hillman, 2013), no previous 
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studies investigated effects of sugars on brain functions underpinning cognitive 
processes.  
 
The impact of amino acids ingestion on brain functions. 
Amino acids present in several protein-based meals are essential to the brain to 
function adequately (Lieberman, 1999). The brain uses amino acids, such as 
tryptophan and tyrosine, to promote the synthesis of various neurotransmitters 
and neuromodulators, as serotonin, essential for neuronal firing (Laterra et al, 
1999). In particular, it was demonstrated already in the seventies that mono 
ammine neurotransmitters are synthesized in the brain from aromatic amino 
acidy, their precursors and that are present in blood vessels (Daniel et al, 1976). 
Moreover, in highly stressful situations or in pathological conditions, the CNS 
requirements for amino acids may change and in turn changes in the 
neurotransmitters synthesis can be detected (Baranyi et al, 2016).  
In line with these findings, there is evidence that when peripheral concentration 
of any of the precursors varies, consequences for the brain metabolism, function, 
and behavior can be observed (Young, 2013). 
 
Amino acids, as L-leucine (Mellinkoff et al, 1956; Thimister et al, 1996), L-
glutamine (Gannon and Nuttall, 2010; Greenfield et al, 2009), and L-
phenylalanine (Liddle, 2000) modulate appetite in healthy subjects and obese. 
Previous studies have reported effects on digestive functions (Ballinger and 
Clark, 1994) and food intake (Colombel et al, 1988) after L-tryptophan intake .  
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L-Tryptophan is an essential amino acids found in food and is the precursor of 
serotonin (Young, 2013). As the proportion of carbohydrate relative to protein 
increases, so does the level of brain serotonin. Consistent with alteration of 
serotonin, the availability of tryptophan to the brain can alter also behavioral 
factors such as alertness, level of depression, aggression, and pain sensitivity 
(Jenkins et al, 1987).  
 
L-Tryptophan was demonstrated to have an influence on the activity in prefrontal 
regions that affect cognitive control and emotion processing (Dantzer et al, 2011; 
Passamonti et al, 2012; Seymour et al, 2012; Williams et al, 2007). In fact, 
tryptophan depletion is linked to reduced activity in the insula (Krämer et al, 
2011), that is involved in decision making in potential aggressive situations and 
to changes in the DMN that may reduce depressive mood (Kunisato et al, 2011). 
However, while studies on tryptophan depletion as regulation of serotonin were 
extensively investigated, no previous studies from our knowledge investigated 
the effects of amino acids on food-reward mechanism using neuroimaging 
techniques. While the effects of sugars on the food-reward system are well 
documented, the effects of amino acids on brain regions involved in satiety and 
appetite are unknown. 
 
In the present work we extensively study the effects of sugars and amino acids 
on the food-reward system. Afterwards, we focus on glucose and fructose effects 
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on cognitive functions, by investigating two of the most common dimensions of 
cognitive functions such as working memory and response inhibition.  
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Aim of the present work and hypothesis. 
The present PhD thesis aims at investigating the brain-gut matrix. First, through a 
systematic review of the literature, previous studies assessing the effects of 
nutrients on brain functions were examined to identify a common research 
methodology and related results. On the basis of previous works, we 
hypothesized that brain areas involved in the food-reward circuit are activated in 
opposite directions, by gut peptides linked to satiety or to appetite stimulation.  
We performed afterwards a set of studies investigating the effects of sugars and 
amino acids on satiety hormones and Resting state (RS) functional networks 
involved in appetite regulation. Specifically we focused on the effects of L-
Tryptophan and L-Leucine on the human gut-brain system, using a multimodal 
approach, integrating physiological and neuroimaging data. 
Finally, we investigated more specifically the effects of sugars on cognitive 
functions, discriminating their effects on working memory and response inhibition. 
In particular, as glucose and fructose follow different metabolic processes at the 
cellular level, at the brain level sugars and amino acids may also act differentially 
on regions underpinning different neural functions. 
In the present work, a randomized double-blinded cross-over design was used 
combining the investigation of gut-hormones with multimodal neuroimaging 
approach (fMRI) after nutrients administration.   
The present work is intended to be exploratory aiming at having a global 
overview of the studies investigating the brain-gut matrix and to set a common 
ground for future investigations in the field.!!
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A B S T R A C T
The brain–gut-axis is an interdependent system aﬀecting neural functions and controlling our eating behaviour.
In recent decades, neuroimaging techniques have facilitated its investigation. We systematically looked into
functional and neurochemical brain imaging studies investigating how key molecules such as ghrelin, glucagon-
like peptide-1 (GLP-1), peptide tyrosine–tyrosine (PYY), cholecystokinin (CCK), leptin, glucose and insulin in-
ﬂuence the function of brain regions regulating appetite and satiety.
Of the 349 studies published before July 2016 identiﬁed in the database search, 40 were included (27 on
healthy and 13 on obese subjects).
Our systematic review suggests that the plasma level of ghrelin, the gut hormone promoting appetite, is
positively correlated with activation in the pre-frontal cortex (PFC), amygdala and insula and negatively cor-
related with activation in subcortical areas such as the hypothalamus. In contrast, the plasma levels of glucose,
insulin, leptin, PYY, GLP-1 aﬀect the same brain regions conversely. Our study integrates previous investigations
of the gut-brain matrix during food-intake and homeostatic regulation and may be of use for future meta-
analyses of brain-gut interactions.
1. Introduction
The brain–gut axis is an interdependent system that aﬀects neural
function and controls our eating behaviour through biochemical sig-
nalling between the endocrine and nervous system through hormonal
peptides in the gastrointestinal tract (Huda et al., 2006; Steinert et al.,
2017; Wren and Bloom, 2007). The two main families of gastro-
intestinal (GI) hormones are a) Appetite stimulators, such as ghrelin, a
28 amino acid peptide that promotes meal initiation by increasing ap-
petite and hunger feelings (Cummings et al., 2001; Kojima et al., 1999),
and b) Satiety stimulators, such as the gut hormones glucagon-like
peptide-1 (GLP-1), peptide tyrosine tyrosine (PYY3-36) cleaved from
PYY1-36, cholecystokinin (CCK) and leptin that signal the brain to
decrease hunger and promote meal cessation (Figlewicz, 2003; Woods
et al., 1998). Next to these GI hormones, insulin, a pancreatic hormone,
as well as insulin regulated glucose, play a major role in human me-
tabolism and eating behaviour (Figlewicz, 2003; Woods et al., 1998).
Neuroimaging techniques have greatly facilitated the investigation
of human brain–gut interactions in recent decades. Pioneering studies
(Liu et al., 2000) combining functional magnetic resonance imaging
(fMRI) with hormonal blood analyses have demonstrated a direct link
between changes in plasma concentrations in hormones and modiﬁca-
tions in brain regions that are part of the neural circuit of appetite, as
identiﬁed by Woods et al. (1998). In particular, increased insulin
plasma levels are linked to changes in brain activity in the anterior
cingulate cortex (ACC), in the orbitofrontal cortex (OFC), in the sen-
sorimotor cortex and in the hypothalamus. On the other hand, it is well
established that ghrelin (Malik et al., 2008) acts through the
http://dx.doi.org/10.1016/j.neubiorev.2017.06.013
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hypothalamus to inﬂuence several brain regions involved in the food-
reward pathway, including the ventral tegmental area (VTA), nucleus
accumbens, amygdala, and hippocampus (Abizaid et al., 2006; Diano
et al., 2006; Nakazato et al., 2001). These ﬁndings suggest that diﬀerent
gut peptides divergently modulate brain activation in the neural circuit
controlling appetite and thereby regulate our prospective eating beha-
viour.
However, studies often report inconsistent ﬁndings making a gen-
eral interpretation diﬃcult. There are diﬀerent reasons for the dis-
crepancies: study designs have been variable with diﬀerent nutrients
ingested (stimulating diﬀerent gut peptides) and diﬀerent paradigms
have been used during fMRI examination.
A general overview of the diﬀerent studies and of the methodologies
used in the ﬁeld is therefore necessary.
In the present study, we systematically reviewed functional and
neurochemical brain imaging studies investigating how the main gut
peptides (ghrelin, PYY3-36, leptin, GLP-1 and CCK), insulin and glucose
inﬂuence activation in brain regions regulating appetite and satiety in
healthy and obese subjects. On the basis of the ﬁndings of these studies,
we hypothesised that the brain areas involved in the food-reward cir-
cuit, such as the anterior cingulate cortex (ACC), the insula and the
hypothalamus, are activated in opposite directions, by gut peptides
linked to satiety or to appetite stimulation.
2. Methods
To ensure high quality reporting, PRISMA guidelines for systematic
reviews were followed (Moher et al., 2015).
2.1. Search strategy
An electronic search was performed using the PubMed database.
The following search terms were used: ((ghrelin OR glucose OR insulin
OR peptide YY OR leptin OR GLP-1 OR cholecystokinin) AND (appetite
OR satiety)) AND (mri OR fmri OR pet OR spect OR imaging OR neu-
roimaging). All studies published before July 2016 were included,
Fig. 1. Flowchart of the selection procedure.
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without any language restriction. Additionally, the reference lists of all
included studies identiﬁed in the database search were manually
screened for relevant studies.
2.2. Selection criteria and study selection
The review included original publications in peer reviewed journals,
observational or interventional study designs and applications of
functional or neurochemical neuroimaging techniques. All the included
articles used a randomised double-blinded placebo-controlled design.
Based on previous studies and on the existing literature (Huda et al.,
2006; Jenkins et al., 1987; Wren and Bloom, 2007), one gut peptide
regulating appetite (ghrelin) and four regulating satiety (peptide YY,
leptin, GLP-1, CCK), as well as insulin and glucose, were investigated.
The current review focuses on how changes in plasma concentration of
gut hormones result in modiﬁcations of brain functions regulating ap-
petite and satiety.
After inspection for duplicates, the titles and abstracts of all records
were reviewed. Publications that clearly did not meet inclusion criteria
were excluded. The decision for inclusion or exclusion of the remaining
publications was made on the basis of a review of the full texts. The
whole process was independently conducted by two reviewers (DZ, SB).
In case of disagreement, reviewers discussed their reasons for initial
inclusion and exclusion. If consensus was not reached, a third reviewer
(AS) was included.
2.3. Recorded variables, data extraction and analysis
The recorded variables for each article included in the review were:
authors and year of publication, study design, assessed peptides, ad-
ministered substance, amount of nutrient received, modality of ad-
ministration, imaging method, number of healthy subjects, number of
obese subjects, gender distribution, age, Body max index (BMI), brain
region investigated, analysed brain regions, statistical thresholds and
main ﬁndings. If overlaps between subjects were suspected but the
original publications did not contain information on that topic, we
contacted the authors and included the obtained data in the review.
3. Results
3.1. Identiﬁed studies
Of 343 publications found in the PubMed database and 6 articles
identiﬁed in the reference lists, 40 articles were included in this review.
244 publications did not meet the inclusion criteria (e.g. animal
models, case reports, review articles, pathological conditions) and were
thus excluded. 66 studies were excluded since they investigated appe-
tite without including any brain examination or hormone administra-
tion.
A ﬂowchart of the selection procedure, with the included and ex-
cluded studies, is shown in Fig. 1.
3.2. Study characteristics
Of the 40 included articles, 17 studies used fMRI with a “food-cue
paradigm” (van Bloemendaal et al., 2014; De Silva et al., 2011; Douglas
et al., 2015; Goldstone et al., 2014; Grosshans et al., 2012 Heni et al.,
2014, 2015, p. 201; Hinkle et al., 2013; Karra et al., 2013; Kroemer
et al., 2013a,b, 2015; Leidy et al., 2013; Malik et al., 2008; Page et al.,
2011; Rosenbaum et al., 2008; Wallner-Liebmann et al., 2010), eleven
an “on-oﬀ treatment related block design” (Batterham et al., 2007;
Eldeghaidy et al., 2016; Jones et al., 2012; Lassman et al., 2010; Li
et al., 2012; Little et al., 2014; Liu et al., 2000; Purnell et al., 2011;
Spetter et al., 2014; Sun et al., 2014), ﬁve a resting state fMRI (rsfMRI)
paradigm (Jastreboﬀ et al., 2016; Page et al., 2013; Wölnerhanssen
et al., 2015; Wright et al., 2016; Zhang et al., 2015) and ﬁve studies an
fMRI-ASL (arterial spin labelling) sequence (two studies used both
rsfMRI and ASL) (Jastreboﬀ et al., 2016; Lennerz et al., 2013; Page
et al., 2009, 2013; Schilling et al., 2014). Four were neurochemical
imaging studies using positron emission tomography (PET) (Gautier
et al., 2000; Pannacciulli et al., 2007; Savage et al., 2014; Tataranni
et al., 1999).
All included studies were published between 2007 and 2016. 13
studies investigated the eﬀect of the appetite-stimulating hormone
ghrelin (Batterham et al., 2007; Goldstone et al., 2014; Jastreboﬀ et al.,
2016; Jones et al., 2012; Kroemer et al., 2013a,b, 2015; Leidy et al.,
2013; Li et al., 2012; Malik et al., 2008; Savage et al., 2014; Sun et al.,
2014, 2015), while 30 studies investigated the impact of satiety-indu-
cing hormones and glucose (Batterham et al., 2007; van Bloemendaal
et al., 2014; De Silva et al., 2011; Douglas et al., 2015; Eldeghaidy et al.,
2016; Gautier et al., 2000; Grosshans et al., 2012; Heni et al., 2014,
2015; Hinkle et al., 2013; Jastreboﬀ et al., 2016; Kroemer et al., 2013b,
2015; Leidy et al., 2013; Lennerz et al., 2013; Li et al., 2012; Liu et al.,
2000; Page et al., 2009, 2011, 2013; Pannacciulli et al., 2007; Purnell
et al., 2011; Rosenbaum et al., 2008; Schilling et al., 2014; Spetter
et al., 2014; Tataranni et al., 1999; Wallner-Liebmann et al., 2010;
Wölnerhanssen et al., 2015; Wright et al., 2016; Zhang et al., 2015).
Eight studies focused on glucose (Gautier et al., 2000; Heni et al., 2014;
Lennerz et al., 2013; 2009, Page et al., 2011; Purnell et al., 2011;
Wallner-Liebmann et al., 2010; Wright et al., 2016), 15 on insulin (van
Bloemendaal et al., 2014; Gautier et al., 2000; Heni et al., 2014;
Jastreboﬀ et al., 2016; Kroemer et al., 2013a; Lennerz et al., 2013; Li
et al., 2012; Liu et al., 2000; Page et al., 2009, 2013; Schilling et al.,
2014; Tataranni et al., 1999; Wallner-Liebmann et al., 2010;
Wölnerhanssen et al., 2015; Zhang et al., 2015), four on peptide YY
(Batterham et al., 2007; De Silva et al., 2011; Douglas et al., 2015; Leidy
et al., 2013), ﬁve on leptin (Grosshans et al., 2012; Hinkle et al., 2013;
Jastreboﬀ et al., 2016; Kroemer et al., 2015; Rosenbaum et al., 2008),
ﬁve on GLP-1 (van Bloemendaal et al., 2014; Douglas et al., 2015; Heni
et al., 2015, p. 2; Li et al., 2012; Pannacciulli et al., 2007) and four on
CCK (Eldeghaidy et al., 2016; Lassman et al., 2010; Li et al., 2012; Little
et al., 2014).
To assess brain changes associated with these gut peptides, a broad
variety of nutrients with extensive diﬀerences in protein load were
administered. In 16 studies, subjects directly received the target nu-
trient (such as glucose) (Batterham et al., 2007; De Silva et al., 2011;
Eldeghaidy et al., 2016; Heni et al., 2014, 2015; Hinkle et al., 2013;
Jones et al., 2012; Kroemer et al., 2013a,b; Little et al., 2014; Malik
et al., 2008; Page et al., 2009, 2011, 2013; Rosenbaum et al., 2008;
Schilling et al., 2014), while in 24 studies subjects consumed standar-
dised meals (containing for instance: ﬁbres, soy or chocolate milkshake)
with diﬀerent amounts of protein (van Bloemendaal et al., 2014;
Douglas et al., 2015; Gautier et al., 2000; Goldstone et al., 2014;
Grosshans et al., 2012; Jastreboﬀ et al., 2016; Karra et al., 2013;
Kroemer et al., 2015; Lassman et al., 2010; Leidy et al., 2013; Lennerz
et al., 2013; Li et al., 2012; Liu et al., 2000; Pannacciulli et al., 2007;
Purnell et al., 2011; Savage et al., 2014; Schilling et al., 2014; Spetter
et al., 2014; Sun et al., 2014, 2015; Tataranni et al., 1999; Wallner-
Liebmann et al., 2010; Wright et al., 2016; Zhang et al., 2015).
As regards the modality of administration, 12 studies used an in-
travenous canula (Figlewicz, 2003; Goldstone et al., 2014; Grosshans
et al., 2012; Heni et al., 2014; Hinkle et al., 2013; Karra et al., 2013;
Kojima et al., 1999; Liu et al., 2000; Nakazato et al., 2001; Spetter et al.,
2014; Sun et al., 2015), in 22 studies the substances were ingested
orally (Douglas et al., 2015; Eldeghaidy et al., 2016; Gautier et al.,
2000; Heni et al., 2014, 2015; Jastreboﬀ et al., 2016; Karra et al., 2013;
Kroemer et al., 2013a, 2015; Leidy et al., 2013; Lennerz et al., 2013; Li
et al., 2012; Little et al., 2014; Liu et al., 2000; Page et al., 2013;
Pannacciulli et al., 2007; Schilling et al., 2014; Spetter et al., 2014; Sun
et al., 2014, 2015; Tataranni et al., 1999; Wright et al., 2016; Zhang
et al., 2015), in three studies a nasogastric tube was used (Lassman
et al., 2010; Spetter et al., 2014; Wölnerhanssen et al., 2015), while in
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three studies no administration was performed (Grosshans et al., 2012;
Savage et al., 2014; Wallner-Liebmann et al., 2010). The time between
nutrient administration and brain imaging examination varied as well:
in 14 studies, the neuroimaging examination started immediately after
nutrient administration (Batterham et al., 2007; van Bloemendaal et al.,
2014; Douglas et al., 2015; Gautier et al., 2000; Jastreboﬀ et al., 2016;
Jones et al., 2012; Lassman et al., 2010; Li et al., 2012; Malik et al.,
2008; Page et al., 2013, 2011; Purnell et al., 2011; Spetter et al., 2014;
Zhang et al., 2015), while in the other 20 brain signals were recorded
5–120 min after nutrient administration (De Silva et al., 2011;
Eldeghaidy et al., 2016; Gautier et al., 2000; Goldstone et al., 2014;
Heni et al., 2014, 2015; Karra et al., 2013; Kroemer et al., 2013a,b;
Lennerz et al., 2013; Little et al., 2014; Page et al., 2009; Pannacciulli
et al., 2007; Schilling et al., 2014; Sun et al., 2014, 2015; Tataranni
et al., 1999; Wölnerhanssen et al., 2015; Wright et al., 2016). Three
studies investigated long-term eﬀects by focusing on an administration
period between 6 days and 5 weeks (Hinkle et al., 2013; Leidy et al.,
2013; Rosenbaum et al., 2008). As stated above, three studies did not
administer any treatment (Grosshans et al., 2012; Savage et al., 2014;
Wallner-Liebmann et al., 2010).
13 studies included obese participants beside healthy subjects (van
Bloemendaal et al., 2014; Gautier et al., 2000; Grosshans et al., 2012;
Heni et al., 2014, 2015; Hinkle et al., 2013; Jastreboﬀ et al., 2016;
Lennerz et al., 2013; Rosenbaum et al., 2008; Savage et al., 2014; Sun
et al., 2015; Wallner-Liebmann et al., 2010; Zhang et al., 2015), while
27 studies focused only on healthy controls(Batterham et al., 2007; De
Silva et al., 2011; Douglas et al., 2015; Eldeghaidy et al., 2016;
Goldstone et al., 2014; Jones et al., 2012; Karra et al., 2013; Kroemer
et al., 2013a,b, 2015; Lassman et al., 2010; Leidy et al., 2013; Li et al.,
2012; Little et al., 2014; Liu et al., 2000; Malik et al., 2008; Page et al.,
2009, 2011, 2013; Pannacciulli et al., 2007; Purnell et al., 2011;
Schilling et al., 2014; Spetter et al., 2014; Sun et al., 2014; Tataranni
et al., 1999; Wölnerhanssen et al., 2015; Wright et al., 2016). Details
are shown in Table 1.
3.3. Eﬀects of appetite-inducing hormones on the brain: ghrelin
Of the 10 fMRI studies investigating the eﬀects of ghrelin on healthy
subjects, four used a food cue paradigm (Table 2). The ‘food cue
paradigm’, also called “food-picture paradigm”, refers to a block design
in which high/low-energy-dense food pictures were shown in alterna-
tion to non-food pictures in a randomised fashion during the fMRI ex-
amination.
This approach was used for the ﬁrst time by Malik et al. (2008) to
investigate the eﬀect of ghrelin on brain areas controlling appetite.
After placebo (saline) administration, 0.5 mg/kg of ghrelin were in-
jected with a peripheral venous cannula to 21 male healthy participants
over a period of 20 min. In a food-cue paradigm, fMRI was performed
during both the placebo and ghrelin conditions. Appetite scores were
taken regularly during the blood-fMRI examination. Ghrelin increased
the neural response to food pictures in diﬀerent regions of the brain,
including the amygdala, orbitofrontal cortex (OFC), anterior insula, and
striatum, which are all implicated in encoding the incentive value of
food cues. Moreover, the amygdala and OFC responses to ghrelin were
positively correlated with subjects’ self-rated hunger ratings. The re-
lationship between enhanced levels of plasma ghrelin and corticolimbic
activity is conﬁrmed by a similar study of Goldstone et al. (2014) on 21
healthy participants receiving ghrelin or saline injection, in which in-
creased OFC and hippocampus activity were observed after acute
ghrelin administration.
Furthermore, two overlapping fMRI studies of Kroemer et al.
(2013a, 2015) using the same study population (26 healthy controls, 13
women) investigated how glucose and nicotine induced changes in
ghrelin plasma levels and in brain responses during the presentation of
food-related cues. In the ﬁrst study (Kroemer et al., 2013a), fMRI in a
food-cue paradigm was performed after overnight fasting and after a
standardised caloric intake (75 g of glucose). Fasting levels of ghrelin
correlated positively with food-cue reactivity in the OFC and in the
limbic and paralimbic regions, in which ghrelin receptors are densely
concentrated. Moreover, fasting ghrelin levels were associated with an
increase in subjective appetite.
In the second study (Kroemer et al., 2015), nicotine (2 mg) was
administered to fasting subjects and after meal consumption. During
fasting, nicotine administration weakened the correlations between
ghrelin levels and brain activity in the mesocorticolimbic system (hy-
pothalamus and nucleus accumbens). In contrast, after meal adminis-
tration, nicotine increased the correlation between ghrelin plasma le-
vels and activity in the ventromedial prefrontal cortex (vmPFC) and in
the amygdala. These results conﬁrm that nicotine aﬀects how ghrelin
modulates the neural responses of appetite.
Furthermore, ﬁve studies used an ‘on-oﬀ treatment related block
design’ during fMRI examination to investigate the eﬀects of ghrelin on
brain areas controlling appetite and satiation. Nutrients are adminis-
tered during the fMRI examination and the timing of ghrelin plasma
absorption is used to investigate the brain response. This approach was
used for the ﬁrst time by Batterham et al. (2007) to investigate the
eﬀects of ghrelin on brain activity after placebo and PYY administration
(Batterham et al., 2007) on eight healthy males. Ghrelin levels were
negatively correlated with activation in the hypothalamus, ventral
tegmental areas and brainstem after PYY administration. Furthermore,
a negative correlation was shown between activity in these areas and
satiety levels. These ﬁndings are conﬁrmed by the study of Jones et al.
(2012) using the same paradigm, in which an intravenous infusion of
ghrelin (1.25 pmol/kg/min) was injected before and after intragastric
administration of lipids (dodecanoate, C12) to 20 healthy subjects.
During digestion, a decrease in appetite was negatively correlated with
activity in the midbrain, thalamus, hypothalamus, insula, amygdala and
hippocampus.
Two studies using the same sample size (Sun et al., 2014, 2015)
investigated eﬀects of ghrelin on 32 healthy individuals before and after
meal ingestion using the same paradigm. During the fMRI examination,
two diﬀerent milkshake ﬂavours (chocolate and strawberry) were ad-
ministered. Larger post-prandial reductions in ghrelin plasma levels
were associated with a reduced response to the chocolate milkshake in
brain regions, including the midbrain, amygdala, pallidum, hippo-
campus, insula and medial OFC. Using the same paradigm, Li et al.
(2012) investigated how ingested fat, glucose, protein, and water
modulated brain activation in 14 healthy men. In line with previous
ﬁndings (Sun et al., 2014), activation in the middle insula, amygdala
and lateral OFC also correlated with changes in ghrelin levels after fat
administration and glucose. Although this study did not demonstrate a
direct correlation between cerebral activity and plasma ghrelin levels
and appetite, it showed that ghrelin levels decreases after nutrient ad-
ministration.
Leidy et al. (2013) used fMRI to conﬁrm these results, by exploring
brain activation in response to food cues in 20 late adolescent girls who
consumed either a normal protein breakfast, a high protein breakfast,
or who skipped breakfast continuously for six days. In agreement with
previous evidence, ghrelin plasma levels decreased after the high pro-
tein breakfast, and reduced activation was observed in the amygdala,
hippocampus and para-hippocampus.
Finally one PET study focused on ghrelin and brain-related neuro-
chemical changes (Savage et al., 2014). This study included 8 subjects
of normal weight and 19 obese subjects and investigated midbrain
dopaminergic neurons (DA type 2/type 3 receptor (D2/D3R)). In
healthy individuals, fasting ghrelin correlated negatively with dopa-
minergic binding potential in the midbrain and nucleus accumbens.
3.4. Eﬀects of glucose and satiety inducing hormones on the brain: glucose,
insulin, peptide YY, leptin, GLP-1, and CCK
19 fMRI studies used a food cue paradigm to explore the eﬀect in
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Table 1 (continued)
Author and year Nutrients received Amount of nutrients
received
Administration Hormones investigated Neuro-imagingmodality Paradigm Time after treatment
administration
• Leptin• Ghrelin• Peptide YY• GLP-1
Page et al. (2009) • Insuline• Glucose •
Euglycemia (plasma
glucose ∼95 mg/dl)
• Hypoglicemia(plasma
glucose ∼50 mg/dl)
Intravenous • Insuline• Glucose
fMRI – ASL / • 30 min after the start of
the plasma glucose
decline toward
hypoglycemic levels
• 90 min during the
euglycemic session
Pannaciulli et al. (2007) • Fasting state• Satiety state
Ensure-Plus 1.5 kcal/ml (1
Ca = 4.18 J)
Orally • Glucose• Insulin• GLP-1
PET / 25 min
Gautier et al. (2000) • Fasting state• Satiety state
Ensure-Plus 1.5 kcal/ml (1
Ca = 4.18 J)
Orally • Insulin• Leptin• GLP-1
PET / 25 min
Purnell et al. (2011) • Glucose• Fructose• Saline
0.3 mg/kg Intravenous • Insuline• Glucose
fMRI On-oﬀ treatment related
block design
Immediately
Rosenbaum et al. (2008) • After a six weeks diet:
1. Leptin
2. Placebo (saline)
The leptin dose = leptin
before the diet
Intravenous Leptin fMRI Food-cue 5 weeks
Savage et al. (2014) / / / Ghrelin PET / /
Schilling et al. (2014) • Cortisol
1. Insulin
2. Placebo
• Cortisol: 30 mg• Insulin: 100 I.E./ml •
Cortisol: orally
• Insulin Nasogastric tube
Insulin fMRI – ASL / 30 min
Spetter et al. (2014) • Water• naso-gastric chocolate
milk infusion
• oral chocolate milk
administration
per 100 mL: energy content
of 354 kJ, 3.5 g proteins,
12 g mono and
disaccharides, 2.5 fat g,
0.5 g ﬁbres
• Nasogastric tube• Orally •
Insulin
• Glucose• Ghrelin
fMRI On-oﬀ treatment related
block design
Immediately
Sun et al. (2014) • Milkshake chocolate• Milkshake strawberry •
Milkshake chocolate
• Milkshake strawberry
Orally • Glucose• Insulin• Ghrelin
fMRI On-oﬀ treatment related
block design
30 min
Sun et al. (2015) • Milkshake chocolate• Milkshake strawberry •
Milkshake chocolate
(12 ﬂ oz each of whole
milk, Garelick Farms
brand Chug Chocolate
Milkshake, and Garelick
Farms brand Chug
Cookies and Cream
Milkshake)
• Milkshake strawberry
(32 ﬂ oz of whole milk
to which 6 ﬂ oz of
Hershey’s brand
strawberry syrup was
added)
Orally • Glucose• Insulin• Ghrelin
fMRI On-oﬀ odour (food-non
food) block design
65 min
Tataranni et al. (1999) • Fasting state• Satiety state
Ensure-Plus 1.5 kcal/ml (1
Ca = 4.18 J)
Orally • Glucose• Insulin• GLP-1
PET / 25 min
van Bloemendaal et al.
(2014)
• GLP-1 receptor agonist
exenatide
• Intravenous exendin
9–39 or placebo was
Intravenous GLP-1 fMRI Food-cue Immediately
(continued on next page)
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healthy subjects of glucose and satiety hormones on brain activation
(Table 3).
Six studies investigated the eﬀects of glucose plasma levels on the
brain. In 2011, Page et al. (2011) administered glucose and insulin to
induce a hypoglycaemic or euglycemic status in 21 healthy subjects. A
food cue paradigm was used to investigate brain responses during these
two conditions. Hypoglycaemia preferentially activated limbic-striatal
brain regions (such as the insula, putamen, hypothalamus, caudate) in
response to food cues to produce greater desire for high calorie food,
while euglycemia preferentially activated the medial prefrontal cortex
and resulted in less interest in food stimuli.
In the milestone fMRI study of Liu et al. (2000), glucose was ad-
ministered to 21 healthy volunteers in an ‘on-oﬀ treatment related
block design’. Temporal clustering analysis showed increased activation
in the OFC, frontal lobe and decreased activation in the hypothalamus
after glucose intake. Moreover, before glucose intake, plasma insulin
levels correlated negatively with activity in the hypothalamus.
Woelnerhanssen et al. (2011) used an RS paradigm to explore the
eﬀects of acute glucose and fructose administration on the connectivity
within the basal ganglia network of 12 healthy participants. They found
that after glucose and fructose administration, a glucose-induced in-
crease in rsFC was present in the left caudatus, left putamen, precuneus
and lingual gyrus and − relative to placebo − the glucose-induced
increase in functional connectivity within the basal ganglia/limbic
network correlated positively with glucose-induced insulin release.
Wright et al. (2016) conﬁrmed these results by showing that the con-
nectivity between the left hypothalamus and the superior frontal gyrus
was negatively correlated with glucose plasma levels during fasting
sessions.
In a 2009 study on nine healthy subjects (Page et al., 2009), Page
used an fMRI-ASL sequence to show that increases in glucose blood
levels lead to regional increases in cerebral blood ﬂow (CBF) in the
cerebellum and decreases in the hypothalamus, inferior frontal gyrus,
and anterior cingulate cortex. In a study of 2013 (Page et al., 2013) on
20 HC, the author conﬁrmed the previous results. After a drink con-
taining glucose or fructose, regional CBF was reduced within the hy-
pothalamus, thalamus, insula, anterior cingulate, and striatum after
glucose or fructose compared to baseline. Moreover, changes in the
levels of plasma insulin correlated negatively with changes in regional
CBF in the caudate and putamen in response to glucose ingestion.
Seven studies investigated the eﬀects of insulin plasma levels on
brain activity.
In a study conducted in 2013 (Kroemer et al., 2013b), Kroemer used
the “food cue paradigm” to investigate brain modiﬁcations after
changes in insulin levels. fMRI was used to investigate reactivity to food
cues after overnight fasting and following a standardised caloric intake
(i.e., a 75 g oral glucose) in 26 participants. Increased plasma insulin
levels correlated negatively with activity in the bilateral fusiform gyrus,
superior temporal gyrus, medial frontal gyrus and the limbic system. In
addition, activation in these regions was accompanied by lower sub-
jective appetite ratings. In the same line, Wallner-Liebmann et al.
(2010) showed that during high caloric food cues, insulin levels are
positively associated with hippocampal activity and negatively with
activity in the right superior frontal gyrus and left thalamus in 12
healthy adolescents.
Using an ‘on-oﬀ treatment related block design’ in a study on 14
healthy subjects, Li et al. (2012) showed that levels of plasma insulin
after glucose administration correlated negatively with activity in the
middle insula, thalamus, amygdala and lateral OFC, and – after protein
administration – with activity in the caudate. In the same line, in the
study of Purnell et al. (2011) on nine healthy individuals, increased
activation in the OFC and increases in plasma glucose and insulin levels
were observed during glucose infusion. Spetter et al. (2014) demon-
strated that insulin responses following naso-gastric infusion of cho-
colate milk to 16 healthy individuals correlated positively with brain
activation in the anterior cingulate cortex (ACC) and putamen andTa
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Table 2
Eﬀects of appetite-inducing hormones on the brain: Ghrelin. Decreased activation: “↓”. Increased activation: “↑”.
Authors and year
of publication
Neuro-
imaging
modality
Brain region investigated Type of analysis Threshold Results (HC, if not indicated otherwise)
Batterham et al.
(2007)
fMRI Whole brain + ROIs (Hypothalamus,
substantia nigra, nucleus accumbens,
solitary nucleus and tract, parabrachial
nucleus)
GLM Uncorrected • Hypothalamus ↓• VTA ↓• Brainstem ↓
Goldstone et al.
(2014)
fMRI ROIs (Orbito-frontal cortex, hippocampus,
nucleus accumbens, caudate, anterior
insula, amygdala)
GLM FDR at P < 0.05 • Ghrelin: orbitofrontal cortex↑, Hippocampus↑
Jastreboﬀ et al.
(2016)
fMRI – ASL Whole brain analyses GLM p < 0.05, FWE whole-
brain corrected
• Main eﬀect: Ghrelin: putamen↑, thalamus↑,
insula↑, hypothalamus ↑
• Obese vs. lean: Ghrelin: hypothalamus↑, thalamus↑
, hippocampus ↑
Jones et al.
(2012)
fMRI Whole brain analyses GLM p < 0.05, FWE whole-
brain corrected
• Post-prandial state, ghrelin vs. saline:
1. decrease medulla, midbrain and pons regions of the
brainstem↓, cerebellum↓, hypothalamus (upper)↓,
insula↓, parahippocampal gyrus (amygdala/
hippocampus), postcentral gyrus, thalamus (ventral
anterior nucleus)↓
2. motor cortex and precentral gyrus↑
• Pre-prandial state, ghrelin vs. saline:
1. decrease medulla, midbrain and pons regions of the
brainstem↑, cerebellum↑, hypothalamus (upper) ↑,
insula↑, parahippocampal gyrus (amygdala/
hippocampus), postcentral gyrus, thalamus (ventral
anterior nucleus) ↑
• Eﬀects of ghrelin on C12-induced BOLD signal:
1. In the midbrain, pons and hypothalamus, ghrelin
blocked the increase in BOLD signal in response to
C12, and in the insula and amygdala/hippocampus
the C12 response was reduced by ghrelin to
baseline
Karra et al.
(2013)
fMRI Whole brain analyses Regression p < 0.05, FWE whole-
brain corrected
• Fasted condition:
1. TT group: hypothalamus↑, nucleus accumbens↑ 2.
AA group: hypothalamus↓, nucleus accumbens↓
• Fed condition (ghrelin suppression):
1. TT group: fusiform gyrus↑, the postcentral gyrus↑,
the cuneus↑, caudate ↓
2. AA group: fusiform gyrus↓, the postcentral gyrus↓,
the cuneus↓, caudate ↑
Kroemer et al.
(2013)
fMRI Whole brain + ROIs (ventral striatum,
hypothalamus, midbrain)
• GLM• Correlations
whole brain
uncorrected
P < 0.001/ROIs FWE
correction
• Middle occipital/temporal gyrus ↑• Fusiform gyrus ↑• Superior/medial frontal gyrus ↑• Middle occipital/temporal gyrus R ↑• Inferior frontal gyrus L ↑• Postcentral g., supramarginal gyrus, rolandic
operculum L ↑
• Midbrain (i.e. substantia nigra, red nuclei,
mammilary bodies, ventral tegmental area) L ↑
• Subthalamic nucleus R ↑• Thalamus R ↑• Hypothalamus R ↑• Superior occipital gyrus L ↑• Middle frontal gyrus R ↑• Pallidum, amygdala L ↑• Inferior frontal gyrus R ↑• Inferior temporal g., fusiform gyrus L ↑• Caudate body R ↑• Thalamus (anterior nucleus) L ↑• Middle/superior frontal gyrus L ↑• Medial/superior frontal gyrus, anterior cingulate ↑
Kroemer et al.
(2015)
fMRI Whole brain + ROIs (ventral striatum,
hypothalamus, midbrain)
• GLM• Correlations
whole brain/ROIs
uncorrected
P < 0.001
• Fasting state:
1. Hypothalamus ↑
2. Nicotine administration impact on ghrelin:
3. nucleus accumbens ↓
4. amygdala ↓
5. right hypothalamus ↓
• Fed state:
1. Nucleus accumbens L ↑
2. Amygdala R ↑
3. Hypothalamus R ↑
4. Ventro-medial pre-frontal cortex ↑
Leidy et al.
(2013)
fMRI ROIs GLM p < 0.05, multiple
comparisons corrected
• Amygdala ↓• Hippocampus ↓
(continued on next page)
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negatively in the insula.
The opposite results were found by Schilling et al. (2014) using
fMRI-ASL. Intranasal administration of insulin led to increased CSF in
the insular cortex and putamen in 48 male volunteers.
Finally, one study used PET to investigate the eﬀects of insulin
plasma changes on brain activity. Tataranni et al. (1999) investigated
brain neurochemical changes after satiation (liquid meal intake) or in
the fasting state in 11 healthy subjects. Satiation was associated with
increased CBF in the ventromedial prefrontal cortex, dorsolateral pre-
frontal cortex, and inferior parietal lobule. Furthermore, changes in
plasma insulin concentrations in response to the meal were negatively
correlated with changes in CBF in the insular and OFC.
A recent study of Kromer, as previously discussed (Kroemer et al.,
2015), used fMRI to investigate eﬀects of leptin on food-cue reactivity
before and after a caloric load (oral glucose tolerance test, OGTT) in 26
healthy normal weight never-smokers. During fasting, nicotine admin-
istration increased correlations between leptin levels and activation in
the mesocorticolimbic system. After the OGTT, nicotine increased the
eﬀects of leptin on food-induced neural activity, positively correlating
with activity in the ventromedial prefrontal cortex (vmPFC) and the
amygdala. Nicotine therefore enhances the eﬀect of leptin, which might
in turn reduce appetite.
Five studies investigated the eﬀects of PYY and GLP-1 plasma levels
on the brain.
De Silva et al. (2012), using the “food cue paradigm” during fMRI
examination, and demonstrated that PYY and GLP-17-36 administra-
tion to 16 healthy subjects reduced appetite and in turn altered brain
activity was present in areas as the amygdala, caudate, insula, nucleus
accumbens, OFC and putamen. Similar ﬁndings were also found in the
study of Leidy, as previously described (Leidy et al., 2013), which de-
monstrated that increased PYY plasma concentrations were negatively
correlated with activity in the amygdala, hippocampal and para-hip-
pocampal areas. Douglas et al. (2015) conﬁrmed these results, using the
same paradigm, and showed that high protein meal (beef lunch) in-
creased GLP-1 and PYY3-36 plasma levels and in turn reduced activity
in the anterior cingulate and insula in 21 healthy subjects. Moreover,
GLP-1 levels correlated negatively with activation in the middle insula
and lateral OFC after both glucose and protein administration. On the
contrary, Batterham et al. (2007), using the ‘on-oﬀ treatment related
block design’, showed that with high plasma PYY concentrations, mi-
micking the fed state, there was increased neural activity in the cau-
dolateral OFC (as insula and anterior cingulate cortex).
In a fMRI-ASL on 42 healthy participants, Pannacciulli et al. (2007)
showed that, in the postprandial state, there was an increased plasma
concentration of GLP-1, which was positively correlated with increased
rCBF in the left dorsolateral prefrontal cortex (including the left middle
and inferior frontal gyri) and hypothalamus.
Finally, four studies investigated CCK eﬀects at the brain level. A
study previously reported by Li et al. (2012) using an ‘on-oﬀ treatment
related block design’ on 14 healthy subjects, showed that levels of
plasma CCK after glucose administration correlated negatively with
activity in the caudate and in the thalamus. Moreover, in a work of
Eldeghaidy on 17 healthy adults, an fMRI examination was performed
assessing how prior consumption of an HFM or water load modulates
reward, homeostatic, and taste brain responses to the subsequent de-
livery of oral fat. Their ﬁndings show that an individual’s plasma CCK
concentration correlated negatively with brain activation in taste and
oral somatosensory areas, insula, amygdala and thalamus. A similar
study of Little et al. (2014) administering to 12 healthy subjects an
intragastric infusion (250 mL) of 1 M glucose and predosing with dex-
loxiglumide (CCK receptor antagonist) or 1 M glucose + placebo, or
0.9% saline (control) + placebo, highlighted a CCK1-receptor
Table 2 (continued)
Authors and year
of publication
Neuro-
imaging
modality
Brain region investigated Type of analysis Threshold Results (HC, if not indicated otherwise)
• Middle Frontal Gyrus ↓
Li et al. (2012) fMRI ROIs (hypothalamus, insula, thalamus,
parahippocampal/hippocampal cortex,
caudate, putamen, amygdala, and OFC)
• GLM• Correlations
P < 0.05 corrected
with Monte Carlo
simulations
1 Soybean oil emulsion:
• Middle insula↑• Amygdala↑• Latera orbito-frontal cortex↑
1 Glucose:
• Middle insula↑• Latera orbito-frontal cortex↑
1 Whey protein:
• Amygdala↑
Malik et al.
(2008)
fMRI Whole brain • GLM• Correlations
p < 001 uncorrected • Amygdala↑• Orbitofrontal cortex ↑• substantia nigra↑• ventral tegmental area↑• caudate↑• hippocampus ↑• insula↑• occipital gyrus↑• left pulvinar ↑• left fusiform ↑
Savage et al.
(2014)
PET ROIs (substantia nigra) Correlations P < 0.05 • HC:
○ Substantia nigra↑
• Obese:• no correlation
Sun et al. (2014) fMRI Whole brain + ROIs (insula,
hippocampus, amygdala, caudate,
putamen, midbrain, pallidum, nucleus
accumbens, and hypothalamus)
• GLM• Correlations
p < 0.05 Family Wise
Error
• Midbrain↑• Amygdala↑• Pallidum↑• Insula↑• Hippocampus↑• Middle orbito-frontal cortex ↑
Sun et al. (2015) fMRI Whole brain + ROIs (insula, amygdala) • GLM• Correlations
p < 0.05 Family Wise
Error
• Odor > OL• Higher satiety than hunger• cerebellum ↓
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dependent increase in Blood oxygenation level dependent (BOLD)
signal in the motor cortex. Lastly, a study of Lassman et al. (2010),
investigating the brain activation responses to ingested lipid (dodeca-
noic acid) or saline (control) on 19 healthy subjects with and without
prior administration of the CCK receptor antagonist dexloxiglumide,
showed signiﬁcant interaction of dexloxiglumide before treatment on
brain stem, hypothalamus, precuneus, cingulate cortex, temporal gyrus
and caudate.
The main areas involved in the neural circuit of appetite and target
of the gut peptides are shown in Fig. 2.
3.5. Eﬀects of gut peptides on the brain in patients with obesity
13 of the included studies focused on the neural eﬀects of gut
peptides in obese subjects (van Bloemendaal et al., 2014; Gautier et al.,
2000; Grosshans et al., 2012; Heni et al., 2014, 2015; Hinkle et al.,
2013; Jastreboﬀ et al., 2016; Lennerz et al., 2013; Rosenbaum et al.,
2008; Savage et al., 2014; Sun et al., 2015; Wallner-Liebmann et al.,
2010; Zhang et al., 2015). Three studies were conducted to test the
eﬀects of ghrelin on brain areas of obese subjects in comparison to lean
subjects (Jastreboﬀ et al., 2016; Karra et al., 2013; Savage et al., 2014).
Karra et al. (2013) investigated the relation between changes in plasma
ghrelin concentrations and obesity, focusing on the obesity-associated
gene (FTO). This fMRI study examined how brain responses to food
cues diﬀered between 12 carriers of the AA genotype and 12 carriers of
the TT allele after consumption of a standard meal. During the fasted
state, activation in the hypothalamus, nucleus accumbens, cingulate
gyrus and OFC correlated positively with ghrelin levels in the AA group
and with greater feelings of hunger. These results show that the FTO
gene and ghrelin are key mediators of ingestive behaviour.
Jastreboﬀ et al. (2016) tested how glucose and fructose adminis-
tration modulated brain perfusion in 14 lean and 24 obese subjects.
Obese patients showed high levels of perfusion in the hypothalamus
and thalamus that was related to high plasma concentrations of ghrelin,
while low levels of perfusion in the prefrontal cortex and anterior
cingulate cortex were linked to low plasma levels of ghrelin (Jastreboﬀ
et al., 2016; Savage et al., 2014). Furthermore, Savage and colleagues
found diﬀerent brain responses between lean and obese subjects with
respect to ghrelin plasma levels (Savage et al., 2014). Using positron
emission tomography (PET) imaging, they investigated the expression
of DA type 2/t 3 receptors (D2/D3R) in eight subjects with normal
weight compared to 19 obese subjects. Ghrelin levels and D2/D3R
binding potential (BPND) in the substantia nigra were positivelyTa
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Fig. 2. Main target regions of gut peptides.
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correlated in normal weight but not in obese participants.
On the other hand, 11 studies investigated diﬀerences in brain ac-
tivation in obese subjects compared to lean subjects in relation to
changes in glucose and satiety hormones (van Bloemendaal et al., 2014;
Gautier et al., 2000; Grosshans et al., 2012; Heni et al., 2014, 2015;
Hinkle et al., 2013; Jastreboﬀ et al., 2016; Karra et al., 2013; Lennerz
et al., 2013; Rosenbaum et al., 2008; Zhang et al., 2015). In one study,
both ghrelin and insulin were measured (Jastreboﬀ et al., 2016).
Lennerz et al. (2013) focussed on glucose plasma levels and ex-
plored resting state connectivity in 12 overweight men after a high
glycaemic (high GI) or a low glycaemic meal (low GI). Compared with a
low GI meal, a high GI meal decreased plasma glucose, increased
hunger and enhanced activation in the nucleus accumbens, striatum
and olfactory area.
Heni et al. (2014, 2015) explored the eﬀects of glucose ingestion on
brain activity in 12 lean and 12 obese subjects, using a fMRI food-in-
duced paradigm. The hypothalamic response to high caloric food cues
correlated negatively with changes in blood glucose levels 30 min after
glucose ingestion, while activation in the ACC and OFC correlated ne-
gatively with increased plasma insulin levels 120 min after glucose
ingestion. These eﬀects can be observed in both the obese and lean
groups. In a similar study, Jastreboﬀ et al. (2016), conﬁrmed these
results, by showing that obese adolescents exhibited decreased CBF in
the PFC, striatum and hypothalamus after drinking glucose. The hip-
pocampus, an area implicated in the processing of high caloric food
pictures, was also identiﬁed by Wallner-Liebmann et al. (2010)), which
found a positive correlation between hippocampus activity and waist
circumference.
Insulin-related brain changes were also investigated by Gautier
et al. (2000) in a study on 11 lean and 11 obese subjects, that combined
PET and fMRI-ASL sequences after fasting or satiation (liquid meal). A
converse correlation was found between changes in plasma insulin
concentrations and changes in rCBF in the precuneus, orbitofrontal
cortex, putamen and thalamus in obese and lean subjects. This study
raises the possibility that activation in OFC (involved in the inhibition
of inappropriate response tendencies) and limbic/paralimbic areas
(associated with the regulation of emotion) during eating may be dif-
ferent in obese and lean men.
As regards leptin, and using fMRI in a food cue paradigm, Grosshans
et al. (2012) showed that plasma leptin levels were associated with
brain activation in the ventral striatum and with BMI in 21 obese
subjects. According to this study, leptin is therefore a satiety hormone
linked to increased activation in subcortical regions and to weight gain.
In the same line, and with fMRI in a food-cue paradigm, Rosenbaum
et al. (2008) examined how brain responses to food cues were modu-
lated after subcutaneous injection of leptin in six obese subjects fol-
lowing a diet. During weight loss, leptin-related increases in neural
activity in response to visual food cues were observed in the brain stem,
parahippocampal gyrus, inferior and middle frontal gyri, middle tem-
poral gyrus, and lingual gyrus. Leptin-related decreases were observed
in the hypothalamus, cingulate gyrus, and middle frontal gyrus.
A recent study by Hinkle et al. (2013) conﬁrms these results and
investigated changes in the connectivity of the right hypothalamus in
respect to leptin plasma levels in 10 obese subjects. Using fMRI with a
food cue paradigm, the functional connectivity of the right hypotha-
lamus with the mid-insula and the central and parietal operculae in-
creased after leptin injections, while it decreased with the OFC, frontal
pole and the dorsal ACC.
Apart from insulin, eﬀects of changes in GLP-1 plasma levels on the
brain have also been investigated in obese subjects. van Bloemendaal
et al. (2014) explored how the administration of the GLP-1 receptor
agonist exenatide modulated brain responses to food pictures during a
somatostatin pancreatic-pituitary clamp in 16 obese and 16 normal-
weight subjects. Relative to lean subjects, obese subjects showed in-
creased brain responses to food pictures in the insula, amygdala, pu-
tamen, and OFC. In the same line, in a second study performed in 2015,
Heni et al. (2015) administered 75 g of glucose to promote GLP-1 se-
cretion. Food cue-induced brain activity was assessed with fMRI and
GLP-1 concentrations measured before, 30 and 120 min after glucose
intake. The signiﬁcant increase in GLP-1 levels correlated negatively
with a change in the food cue-induced brain activity in the OFC in lean
and overweight participants. In contrast, postprandial changes in
plasma insulin were associated with OFC activations in lean individuals
only. Finally, using rsfMRI, Zhang et al. (2015) investigated the am-
plitude of low frequency ﬂuctuations of spontaneous signals during
both hunger and satiety states in 20 lean and 20 obese males. Before
food intake, obese men had signiﬁcantly higher baseline activity in the
precuneus and lower activity in the dorsal anterior cingulate cortex
(dACC) relative to lean subjects. After food intake, obese males had
signiﬁcantly lower activity in the dorsal anterior cingulate cortex
(dACC) than lean males. Moreover a signiﬁcant positive correlation was
found between precuneus activation and hunger ratings before food
intake, while dACC activity was negatively correlated with plasma in-
sulin levels before and after food intake in both groups. These results
indicated that both precuneus and dACC may play an important role in
eating behaviour. While precuneus seemed to mediate subjective sa-
tiety, dACC activation rather reﬂected indirect measures of glucose
utilisation.
4. Discussion
To our knowledge, this is the ﬁrst study to systematically review the
eﬀects of diﬀerent gut peptides on brain activation in healthy and obese
subjects. Forty original studies were retrieved, which addressed how
key gut hormones or nutrients, such as ghrelin, glucose, insulin, leptin,
PYY, GLP-1 and CCK, modulate functional brain activation after food
intake. Plasma levels of the appetite-promoting gut hormone ghrelin
positively correlate with activity in the PFC, amygdala and insula and
negatively correlate with activity in subcortical areas such as the hy-
pothalamus. In contrast, satiety-regulating gut hormones or nutrients
like glucose, insulin, letpin, PYY, GLP-1 and CCK aﬀect the same brain
regions in the opposite directions. Nevertheless, the lack of re-
producible studies and the existence of multiple methodological ap-
proaches prevent deﬁnitive conclusions and explains some dis-
crepancies in the results between the diﬀerent studies. The present
review is to be considered as the basis for a future meta-analysis of
brain-gut interactions.
4.1. Nutrient administration
Individual nutrients were administered to stimulate the plasma re-
lease of the investigated hormones. In particular, 22 studies used direct
administration of the target substance (i.e. glucose) (Batterham et al.,
2007; van Bloemendaal et al., 2014; De Silva et al., 2011; Eldeghaidy
et al., 2016; Goldstone et al., 2014; Heni et al., 2014, 2015; Hinkle
et al., 2013; Jastreboﬀ et al., 2016; Jones et al., 2012; Kroemer et al.,
2013a,b, 2015; Lennerz et al., 2013; Malik et al., 2008 Page et al., 2009,
2011, 2013, p. 200; Purnell et al., 2011; Rosenbaum et al., 2008;
Schilling et al., 2014; Wölnerhanssen et al., 2015) and 16 the admin-
istration of a nutrient (for instance chocolate milkshake) that subse-
quently stimulated the production of gut peptides (i.e. ghrelin and PYY)
(Douglas et al., 2015; Gautier et al., 2000; Grosshans et al., 2012; Karra
et al., 2013; Leidy et al., 2013; Li et al., 2012; Liu et al., 2000;
Pannacciulli et al., 2007; Savage et al., 2014; Spetter et al., 2014; Sun
et al., 2014, 2015; Tataranni et al., 1999; Wallner-Liebmann et al.,
2010; Wright et al., 2016; Zhang et al., 2015). Studies also employed
diﬀerent administration schemes: while in 12 studies the administration
was intragastric or intravenous (Batterham et al., 2007; van
Bloemendaal et al., 2014; De Silva et al., 2012; Goldstone et al., 2014;
Hinkle et al., 2013; Jones et al., 2012; Malik et al., 2008; Page et al.,
2009, 2011; Purnell et al., 2011; Rosenbaum et al., 2008; Schilling
et al., 2014; Wölnerhanssen et al., 2015), in 24 investigations the
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nutrients were ingested orally (Douglas et al., 2015; Eldeghaidy et al.,
2016; Gautier et al., 2000; Grosshans et al., 2012; Heni et al., 2014,
2015; Jastreboﬀ et al., 2016; Karra et al., 2013; Kroemer et al., 2013a,b,
2015; Leidy et al., 2013; Lennerz et al., 2013; Li et al., 2012; Liu et al.,
2000; Page et al., 2013; Pannacciulli et al., 2007; Savage et al., 2014;
Spetter et al., 2014; Sun et al., 2014, 2015; Tataranni et al., 1999;
Wallner-Liebmann et al., 2010; Wright et al., 2016; Zhang et al., 2015).
Oral intake aimed to mimic the consumption of daily meals, whereas
intragastric/intravenous administration aimed to directly assess the
eﬀects of the target hormones. The diﬀerence in the acquisition pro-
cedure leads to two main consequences in the comparison of the stu-
dies: a) intragastric/intravenous administration could lead to un-
comfortable feelings and therefore inﬂuence data acquisition, b)
diﬀerences in the timing of nutrient absorption leads to diﬀerences in
the timing of the fMRI examination (immediately after nutrient ad-
ministration or after 10, 30, 120 min).
4.2. Diﬀerences in the paradigm during the fMRI examination
Diﬀerent paradigms were used during the neuroimaging examina-
tion to investigate the eﬀects of gut peptides on brain activation. 16
studies (van Bloemendaal et al., 2014; De Silva et al., 2011; Douglas
et al., 2015; Goldstone et al., 2014; Grosshans et al., 2012; Heni et al.,
2014, 2015; Hinkle et al., 2013; Karra et al., 2013; Kroemer et al.,
2013a,b, 2015; Leidy et al., 2013; Malik et al., 2008; Page et al., 2011;
Rosenbaum et al., 2008; Wallner-Liebmann et al., 2010) used a “food-
cue paradigm” to investigate eﬀects of gut peptides on feelings of ap-
petite and neural activity during high and low caloric food cues. The
“food-cue paradigm” refers to a block design in which high/low energy
dense food pictures were shown alternatively to non-food pictures in a
randomised fashion during the fMRI examination.
On the other hand, 9 studies (Batterham et al., 2007; Eldeghaidy
et al., 2016; Jones et al., 2012; Li et al., 2012; Liu et al., 2000; Purnell
et al., 2011; Spetter et al., 2014; Sun et al., 2014, 2015) used an ‘on-oﬀ
treatment related block design’ to assess the direct eﬀect of the target
compound on the brain. Nutrients are administered during the fMRI
examination and the timing of hormonal plasma absorption is used to
investigate the brain response. The best example is a milestone study by
Liu et al. (2000), in which the statistical model to investigate the BOLD
signal is based on the increasing insulin plasma levels after glucose
administration. The last paradigm used during fMRI examination was
that of the classical resting state. At the highest point of plasma hor-
mone absorption, an fMRI sequence is performed; the subjects had to
relax and not think about anything in particular. Diﬀerences within
brain networks involved in appetite and satiety regulation were then
investigated.
Although these paradigms are diﬀerent, the absence of any cogni-
tive tasks makes the results rather comparable. The focus is on brain
activity changes associated with variations in hormonal plasma con-
centrations.
4.3. Neuroimaging results
In line with subjective feelings of appetite, neuroimaging results
demonstrate that the two classes of gut hormones have opposite eﬀects
on the neural circuit of appetite. In particular, activation in frontocor-
tical regions, such as OFC, ACC and insula correlates positively with
ghrelin plasma levels, and with increased hunger feelings. Subcortical
areas like the thalamus, hippocampus, striatum and hypothalamus
correlated negatively with ghrelin levels. These results have con-
sistently been reported in 8 studies (Batterham et al., 2007; Goldstone
et al., 2014; Jones et al., 2012; Kroemer et al., 2013a, 2015; Li et al.,
2012; Sun et al., 2014, 2015, p. 2), while 2 studies (Leidy et al., 2013;
Savage et al., 2014) found associations in diﬀerent directions. This
discrepancy can perhaps be explained by the use of the food-cue
paradigm that could discriminate between high caloric and low caloric
food cues and therefore be more speciﬁc.
In contrast, plasma levels of satiety-stimulating hormones correlate
negatively with the same cortical areas and positively with subcortical
areas.
The present ﬁndings ﬁt with a model proposed by Woods (Woods
et al., 1998), which embeds gut-brain interactions during food-intake
within the framework of homeostasis regulation. After food intake, the
circulating adipose signals (ghrelin and insulin) penetrate the blood
brain barrier and stimulate receptors on neurons in the hypothalamus
(Woods et al., 1998). Satiety signals generated by ingested food enter
subcortical areas, such as amygdala and striatum, where they inﬂuence
reﬂexes related to the acceptance or rejection of food. In a second step,
the hypothalamus sends signals to cortical areas, such as the OFC, ACC
and insula, as part of the reward mechanism, where cognitive in-
formation is integrated with adiposity signals. A higher cognitive eva-
luation is performed and the prospective eating behaviour is de-
termined. This model of integration between gut peptides, brain
responses and subjective feelings explains the opposite direction of the
correlations between cortical and subcortical brain activation, sub-
jective satiety and appetite feelings and hormonal plasma levels.
Increased activity of adiposity signals enhances the ability of satiety
signals to terminate a meal or of appetite signals to continue eating.
Although this pattern is clear in the majority of the included studies
(De Silva et al., 2012; Douglas et al., 2015; Gautier et al., 2000;
Grosshans et al., 2012; Heni et al., 2014, 2015; Hinkle et al., 2013;
Jastreboﬀ et al., 2016; Kroemer et al., 2013b, 2015; Lennerz et al.,
2013; Li et al., 2012; Page et al., 2013; Rosenbaum et al., 2008; Spetter
et al., 2014, p. 20; Tataranni et al., 1999; Wright et al., 2016; Zhang
et al., 2015), discrepancies across studies may be due to the peculiarity
of the diﬀerent satiety stimulating hormones that have intrinsic prop-
erties and therefore aﬀect diﬀerent brain areas in diﬀerent ways.
4.4. Diﬀerences between a clinical obese and a healthy lean population
Finally, our last result concerns the eﬀects of gut peptides on brain
activation in obese subjects. The included studies provide little, if any,
evidence for alterations in obese compared to lean subjects. In parti-
cular, the results of gut hormones on brain regional activity in the obese
population is not reproduced by any study using the same amount of
ingested nutrients and the same paradigm. Moreover, it is very hard to
compare brain changes in obese and lean subjects due to a lack of
statistical comparisons between the two groups within each study.
Moreover, the discrepancies of results can be explained by metho-
dological issues (the diﬀerent nutrients administered, diﬀerent peptides
investigated and diﬀerent paradigms used during the fMRI examina-
tion) and by the low number of studies performed and the lack of re-
producibility of the results. Further investigations on the diﬀerential
eﬀects of gut peptides on the appetite circuit between obese and lean
population are therefore needed.
4.5. Limitations
A ﬁrst limitation that we want to highlight is that most studies
didn’t control for possible pre-existing preferences for the participants
for certain type of foods and this can impact the studies results.
Moreover, the results might be inﬂuenced by psychopathological states,
such as mood disturbances, which have not been systematically as-
sessed in the included studies. Also the use of cannabinoids or psy-
choactive substances was self-reported and consequently not necessa-
rily accurate (Becker et al., 2015). These factors may confound the
neuroimaging results.
The amount of nutrients ingested varied in several studies and this
hampers comparability. Moreover, the timing of the fMRI examination
was very diﬀerent across studies. It varied from an examination im-
mediately after substance intake to 6 weeks post-administration.
Although (as stated above) the timing was in accordance with the aim
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of the investigation, it cannot be denied that this may result in a con-
founding factor and make the studies poorly comparable. Furthermore,
in neuroimaging studies addressing brain-gut interactions in healthy
subjects, the sample sizes were modest because the design of the study
makes recruitment of subjects relatively diﬃcult.
Finally, we suggest that studies including randomised samples that
express preferences for speciﬁc food have to be conducted. Moreover,
psychopathological states, such as mood disturbances in the partici-
pants, have to be previously screened in order to avoid confounding
factors that can aﬀect the results. Furthermore, studies on eating dis-
orders, such as anorexia and bulimia, can greatly enhance the clinical
relevance of studies of the eﬀects of speciﬁc nutrients on brain regions
regulating appetite. It would also be interesting to investigate cognitive
changes (such as working memory performance) after nutrient admin-
istration, as shown by pioneering studies (Borgwardt et al., 2012;
Schmidt et al., 2014).
Finally, studies using a standardised amount of ingested nutrient
should be performed, since the amount of ingested nutrients can also
lead to diﬀerences in the strength of brain activation
5. Conclusion
The present article systematically reviewed the existing literature
investigating how gut peptides inﬂuence brain regions regulating ap-
petite and satiety in healthy and obese subjects. The activation of brain
areas controlling the brain-gut matrix occurs in opposite directions in
respect to satiety or appetite regulation. The present review can en-
hance our understanding of the physiology of eating behaviour and the
pathophysiology of obesity and eating disorders and is the basis for a
future meta-analysis in the ﬁeld.
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Differential effects of L-tryptophan 
and L-leucine administration on brain 
resting state functional networks 
and plasma hormone levels
Davide Zanchi1,*, Anne Christin Meyer-Gerspach2,*, Claudia Suenderhauf1,  
Katharina Janach2, Carel W. le Roux3, Sven Haller4,5,6,7,8, Jürgen Drewe9,  
Christoph Beglinger9, Bettina K. Wölnerhanssen2,9,† & Stefan Borgwardt1,†
Depending on their protein content, single meals can rapidly influence the uptake of amino acids into 
the brain and thereby modify brain functions. The current study investigates the effects of two different 
amino acids on the human gut-brain system, using a multimodal approach, integrating physiological 
and neuroimaging data. In a randomized, placebo-controlled trial, L-tryptophan, L-leucine, glucose and 
water were administered directly into the gut of 20 healthy subjects. Functional MRI (fMRI) in a resting 
state paradigm (RS), combined with the assessment of insulin and glucose blood concentration, was 
performed before and after treatment. Independent component analysis with dual regression technique 
was applied to RS-fMRI data. Results were corrected for multiple comparisons. In comparison to glucose 
and water, L-tryptophan consistently modifies the connectivity of the cingulate cortex in the default 
mode network, of the insula in the saliency network and of the sensory cortex in the somatosensory 
network. L-leucine has lesser effects on these functional networks. L-tryptophan and L-leucine also 
modified plasma insulin concentration. Finally, significant correlations were found between brain 
modifications after L-tryptophan administration and insulin plasma levels. This study shows that acute 
L-tryptophan and L-leucine intake directly influence the brain networks underpinning the food-reward 
system and appetite regulation.
Luminal enteral communication is a key factor in the regulation of appetite, food intake and metabolism. Protein 
digestion to dipeptides or tripeptides and free amino acids modulate digestive functions, glycemia and appetite1–6. 
Protein is currently believed to exert the greatest appetite-suppressing effect of the three macronutrients (carbo-
hydrates, fats and proteins) in animals and humans7. High-protein diets have been extensively studied for their 
ability to reduce total energy intake and body weight7. Mechanisms that have been suggested include stimulation 
of insulin release3, postprandial thermogenesis1, intestinal gluconeogenesis7, and direct effects of amino acids in 
regions of the brain6. In addition, it has been hypothesized that protein-induced satiation could be due to altera-
tions in the release of gastrointestinal satiation peptides, such as cholecystokinin (CCK), glucagon-like peptide-1 
(GLP-1) and peptide tyrosine tyrosine (PYY). Already in 1956, it was suggested that an elevated concentration 
of plasma amino acids serve as a satiation signal for food intake and thereby results in depressed food intake8. To 
date the effect of specific amino acids on satiation and appetite is only rarely studied.
Amino acids, including L-leucine9,10, L-glutamine11,12, and L-phenylalanine13 modulate appetite and/or glyce-
mia in lean, obese, or type 2 diabetic subjects. The aromatic amino acid, L-tryptophan, is of particular interest, as 
previous studies have reported effects on digestive functions14 and food intake15.
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It is unknown how amino acids affect specific brain regions. After eating, the brain senses a biochemical 
change and then signals satiation, but the precise sequence of events has not been determined. Even for estab-
lished physiological systems such as glucose-insulin regulation, the timing of the interaction between hormonal 
processes and neural events has mostly been inferred from blood sampling studies. Recently, neuroimaging stud-
ies have provided in vivo information about the neuro-anatomical correlates of the regulation of energy intake. 
Temporal orchestration of such systems is, however, crucial to the integration of the neural and hormonal signals 
that control eating behaviour. In a landmark paper demonstrating eating-related neural activity in the brain, the 
response was shown to interact with an internal signal, plasma insulin16. As it was shown that most amino acids 
induce an increase in insulin (possibly due to an increase in GLP-1), amino acids could be one of the signals from 
the gut that interact with the brain through satiation peptides.
The present study was designed to further investigate the luminal influences of nutrients, which orches-
trate gut-brain interactions. The objective was to compare the effects of intragastric L-tryptophan (L-Trp) and 
L-leucine (L-Leu) on brain networks and the release of insulin and glucose. We used plasma levels to repre-
sent physiological differences; this is a reliable measure of appetite and satiety17,18. In particular the association 
between brain activity in areas involved in appetite, appetite and satiety rating scores and levels of insulin and 
glucose was already demonstrated in previous studies16,19.
On the basis of previous studies highlighting the differences between L-Trp and L-Leu on digestive 
functions20, with L-leucine stimulating appetite and L-tryptophan stimulating satiety21, we hypothesized that L-Trp 
would induce a different activation pattern in the brain, leading to modifications in brain networks related to appetite 
and metabolism regulation. The selection of the doses of L-tryptophan was based on the daily intake recommended 
by World Health Organization (WHO)22. The doses are comparable to the amount of L-tryptophan in soybeans in 
a normal portion of an Asian dish. For L-leucine an isocaloric approach to L-tryptophan was chosen. Glucose was 
chosen as a positive control and water as a negative control as we have previously shown effects on brain activity 
with both of them23. We have never intended to do an isocaloric comparison between glucose and amino acids.
Results
Physiological and psychological results. Differences in insulin levels. (Figure 1A) No significant dif-
ferences were found between the treatments in insulin levels at baseline (Time1, before treatment). At Time2, the 
ANOVA was significant (p < 0.001) showing significant differences in insulin plasma levels after the treatments 
administration. In particular, significantly higher insulin concentrations were found after glucose administration 
than with L-tryptophan (p < 0.001), L-leucine (p < 0.001) or with placebo (p < 0.001). Significantly higher insulin 
levels were found after L-tryptophan and L-leucine administration than with placebo (p < 0.001). No statistical 
differences were found between insulin levels after L-tryptophan or L-leucine administration. Cohen’s effect size 
(d): d = 2.37, var(d) = 0.17, p < 0.001.
Differences in glucose levels. (Figure 1B) At baseline (Time1, before treatment), no significant differences in 
glucose levels were found between the treatments At Time2, the ANOVA was significant (p < 0.001) showing sig-
nificant differences in glucose plasma levels after the treatments administration. In particular, significantly higher 
glucose levels were found after glucose than after L-tryptophan (p < 0.001), after glucose than after L-leucine 
(p < 0.001) and after glucose than after placebo (p < 0.001). No significant differences in glucose levels were found 
between the other treatments. Cohen’s effect size (d): d = 3.66, var(d) = 0.27, p < 0.001.
Figure 1. Physiological results. After treatment administration, plasma hormones levels were compared 
though a paired t test. (A) Higher insulin concentrations were found after glucose ingestion than with 
L-tryptophan (p < 0.001), L-leucine (p < 0.001) or placebo (p < 0.001). Moreover, after L-tryptophan and 
L-leucine administration, significantly higher insulin levels were found than with placebo (p < 0.001). No 
statistical differences were found between insulin levels after L-tryptophan and L-leucine intake. (B) Higher 
glucose levels were found after glucose than with L-tryptophan (p < 0.001), L-leucine (p < 0.001) or placebo 
(p < 0.001). No significant differences in glucose levels were found between other treatments.
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Functional connectivity results. From framewise displacement (FD) analyses, no significant effect of 
motion was found between the treatments.
At baseline (Time0), after permutation based non-parametric tests, no significant activation was found in the 
three networks for any group comparison, revealing that, before medication, there were no differences between 
the subjects in functional connectivity.
At Time2, after permutation based non-parametric tests, ANOVA showed significant differences between the 
treatments within each of the three pre-selected networks (p < 0.001). Cohen’s effect size (d) for the default mode 
network was: d = 1.97, var(d) = 0.15, p < 0.001. Cohen’s effect size (d) for the sensorimotor network was: d = 2.72, 
var(d) = 0.23, p < 0.001. Cohen’s effect size (d) for the saliency network was: d = 1.07, var(d) = 0.17, p < 0.001.
In particular, the comparison “L-tryptophan vs. placebo” revealed increased connectivity in the cingulate 
cortex and in the precuneous within the default mode network (DMN), in the somatosensory cortex within the 
sensorimotor network (SMN) and in the bilateral anterior insula within the salience network (SN) (Fig. 2A).
For the comparison “L-tryptophan vs. glucose”, group analyses showed reduced connectivity in areas over-
lapping those in the “L-tryptophan vs. placebo” contrast. In particular, the cingulate cortex and the precuneous 
show higher connectivity within the DMN, the somatosensory cortex within the SMN and the left anterior insula 
within the SN (Fig. 2B).
With respect to the sensorimotor network (SMN), the comparison “glucose vs. L-leucine” revealed signifi-
cantly higher bilateral connectivity in the sensorimotor cortex (Fig. 2C), while the comparison “glucose vs. pla-
cebo” shows broader connectivity in areas including the precuneous (Fig. 2D).
The comparison “L-tryptophan vs. L-leucine” revealed significantly increased connectivity in the cingulate 
cortex within the DMN and in the somatosensory cortex within the SMN (Fig. 2E).
No significant activations where found for the remaining comparisons: “glucose vs. L-tryptophan”, “placebo vs. 
L-tryptophan”, “placebo vs. L-leucine”, “placebo vs. glucose”, “L-leucine vs. L-tryptophan”, “L-leucine vs. glucose” and 
“L-leucine vs. placebo”.
Finally, the interaction effect between time and treatments revealed no significant results.
These results reveal that amino acid administration has extensive effects on the brain, by modifying the con-
nectivity of specific functional networks.
Correlations between imaging and physiological results. After L-tryptophan administration, a pos-
itive correlation (p < 0.05) was found between insulin plasma levels and bilateral activity in the insula within 
the saliency network (Fig. 3.1). Furthermore, after glucose administration, positive correlations were present 
between plasma insulin levels and activity in the sensorimotor area (SMA) within the sensorimotor network 
(SMN) (Fig. 3.2). These results established a link between the role of satiety hormones and connectivity changes 
in the brain after amino acid administration.
VBM Analysis of T1 Images. VBM analysis of the grey matter (GM) revealed no statistical differences 
between the visits at baseline.
Discussion
The current study provides novel insights into the effects of luminal amino acids on gut-brain interactions. The 
present findings suggest that intragastric L-tryptophan (L-Trp) and L-leucine (L-Leu) lead to differential mod-
ifications in insulin and glucose plasma concentrations and in brain networks connectivity, that are related to 
metabolic regulation and appetite sensations.
Our results from laboratory analyses indicate that different amino acids affect specific satiation hormones. In 
particular, L-tryptophan and L-leucine lead to a significant increase in insulin plasma levels when compared to 
water, but at the doses given they do not affect glucose levels. The differential effects of amino acids on insulin but 
not on glucose have been shown before in several studies11. On the other hand, and in line with previous stud-
ies24, glucose is associated with both insulin and glucose plasma levels. As L-Trp and L-Leu have been proposed 
to be involved in food-intake and regulation of energy homeostasis25–27, our findings suggest that L-tryptophan 
and L-leucine are key amino acids that affect satiety and appetite perception. To further explore these dynamic 
interactions, we investigated the effects of these amino acids on brain functional networks that are related to the 
food-reward mechanism.
Our additional findings are related to large-scale alterations in brain networks involved in metabolic regula-
tion after amino acids ingestion. Our results reveal that - compared to glucose and placebo - L-tryptophan gives 
higher connectivity within the default mode network in the cingulate cortex and in the precuneous and within 
the salience network in the bilateral insula. In general, the finding that activity in brain areas regulating appetite 
can be influenced by different nutrients is consistent with previous reports19,28 on modifications after glucose and 
fructose ingestion. Our study extends this research, by focusing for the first time on amino acids ingestion and 
suggesting that L-tryptophan may be a key amino acid that increases brain connectivity in areas controlling the 
metabolic state of the individual.
Moreover, the direct link between satiation hormones and brain areas involved in metabolism regulation is 
confirmed by the positive correlation between brain activity in the insular cortex and insulin plasma levels after 
L-tryptophan administration. These results resemble previous findings in studies with glucose intake and con-
firms that there is a direct link between these regions and food-reward mechanisms16.
Furthermore, in comparison to placebo and glucose, L-tryptophan administration also increases activity 
within the sensorimotor network in somatosensory areas. This is the first study to report large-scale modifications 
in brain activity after L-tryptophan manipulation within the sensorimotor network. The reorganization in the 
sensorimotor network is also evident in the analysis of the effects of glucose administration compared to placebo 
that shows greater activation in somatosensory areas. As demonstrated in a previous study16, the somatosensory 
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area (SMA) integrates sensory and visceral signals associated with protein intake and is therefore one of the main 
brain areas involved in appetite regulation and food-reward mechanism. In our study, its function is confirmed 
by the positive correlation found between changes in activity in SMA and in insulin.
Figure 2. Functional connectivity results. After independent component analyses (ICA), the dual regression 
technique was performed to investigate differences between the different treatments in functional connectivity 
in the DMN, SN and SMN. (A) The comparison “L-tryptophan vs. placebo” revealed increased connectivity 
in the cingulate cortex and in the precuneous within the default mode network (DMN), in the somatosensory 
cortex within the sensorimotor network (SMN) and in the bilateral anterior insula within the salience network. 
(B) The comparison “L-tryptophan vs. glucose” showed altered connectivity in areas overlapping those of the 
previous contrast. In particular, the cingulate cortex and the precuneous show higher connectivity within the 
DMN, the left anterior insula within the SN and the somatosensory cortex within the SMN. (C) The comparison 
“glucose vs. L-leucine” revealed significantly higher connectivity in the bilateral sensorimotor cortex within 
the sensorimotor network. (D) Within the same network (SMN), the comparison “glucose vs. placebo” reveals 
an increase in connectivity in additional areas, including the precuneous. (E) The comparison “L-tryptophan 
vs. L-leucine” revealed significantly increased connectivity in the cingulate cortex within the DMN and in the 
somatosensory cortex within the SMN. No significant activations where found for the remaining comparisons. 
These results reveal that amino acids administration has an extensive influence on the brain, by modifying the 
connectivity of specific functional networks related to appetite perception and emotional regulation.
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Apart from brain modifications related to the food-reward system, we infer that L-tryptophan has an influence 
on cognitive functions and mood regulation. In fact, as demonstrated by different studies manipulating serotonin 
levels, changes in the activity in prefrontal regions can affect cognitive control and emotion processing29–32. In 
particular, as suggested by Kramer33, L-tryptophan depletion is linked to reduced activity in the insula, that in 
turn regulates decision making in potential aggressive situations. On the other side, modulation of L-tryptophan 
leads to changes in the DMN that may reduce depressive mood34. Following this interpretation changes in the 
DMN and SN after L-tryptophan intake can be linked to changes in cognitive functions and emotion processing.
Our last result concerns the role of L-leucine on brain networks at rest. When L-tryptophan was compared to 
L-leucine, no differences were found in the activity in the insular cortex within the SN or within the DMN in the 
precuneous, while significant differences were present in the ACC within the DMN and within the SMN in the 
SMA. Moreover, comparison of glucose vs. L-leucine didn’t find any differences in the DMN or SN.
Even if no previous studies have been conducted on the effects of L-leucine at brain level, these results suggest 
that this amino acid has an effect on brain network connectivity that is not equivalent to that of water, which 
suggests that L-leucine may influence areas responsible for cognitive and metabolic processing. Further investi-
gations are needed to further clarify the effect of this amino acid on brain networks at rest.
It is important to note that this study has some limitations. As in previous neuroimaging studies of the 
brain-gut axis in healthy subjects, our sample size was modest because the design of the study makes recruitment 
of subjects relatively difficult. On the other hand Cohen’s effect size analyses reveal that the treatments show 
already high magnitude. In addition, the present study focused on only two amino acids. Further investigations 
should be conducted on more amino acids. Moreover, plasma levels were measured for glucose and insulin, while 
other hormones might have better detected physiological differences between the different amino acids. Our 
results might potentially be influenced by mood variations not investigated by the oral examination of the health 
status of the participants. However, it is important to highlight that the aim of the present study is to investigate 
changes in brain networks involved in satiation and appetite regulation and changes in hormones levels also 
related to satiation and appetite (as glucose and insulin). Moreover, it is unlikely that there are systematic changes 
in mood associated with specific amino acids (the treatments were randomized), hence it is unlikely that potential 
mood variations systematically biased the current results. Furthermore, the fMRI examination in our study is not 
conditioned by a paradigm, so the results reflect pure resting state functional connectivity and they may not be 
comparable to other studies that use a tasks-related approach. Concerning the fMRI analyses, it is important to 
notice that smoothing may introduce spurious local functional connectivity and affect the subsequent conduction 
of ICA. Therefore, we performed the analyses without applying smoothing and we compared the three functional 
networks with and without smoothing. As expected smoothing improves the quality of the results, making the 
components less noisy. Therefore we decided to work on smoothed data. Lastly, T1 images were acquired at Time0 
but not Time2, but the preprocessing of the Time2 images used the T1 image at Time0, so there were different 
space templates in segment. Since the subjects stayed in the MRI during the treatments administration, the posi-
tion of the subjects remained the same during all the sequences, therefore the registration can be considered quite 
effective. Moreover, we repeated the analyses registering the EPI images directly to standard space. Slightly worse 
registration was seen in the brain networks for the registration directly to MNI, as expected (in fact this is the 
reason why the high-resolution 3DT1 was used). Despite this small reduction in the quality of the spatial normal-
ization, we observed no relevant differences in the brain networks identified by ICA between the two different 
registrations. This shows that the registration first to T1 and then to MNI was the most effective one, and that the 
effect of the spatial registration on the results was marginal.
Figure 3. Correlations between imaging and physiological results. After L-tryptophan administration, a 
positive correlation (p < 0.05) was found between levels of insulin and connectivity in the saliency network 
(A). Furthermore, after glucose administration, positive correlations were present between insulin levels and 
connectivity in the sensorimotor network (SMN) (B). These results establish a link between the role of satiety 
hormones in amino acids synthesis and changes in functional connectivity in the brain.
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Finally, it is important to underline possible confounding results from structural changes in grey matter that 
can influence the response to the treatment administration. To avoid this, VBM analyses were conducted before 
treatment administration and no differences were observed between the visits, thus excluding this potential 
confounder.
Conclusion
The current work provides new insights into acute neural modifications after ingestion of amino acids. By link-
ing satiety hormones and fMRI measurements, this study shows that acute L-tryptophan and L-leucine intake 
directly affect specific brain networks that underpin the food-reward system and appetite regulation.
Materials and Methods
Participants. The protocol was approved by the Ethics Committee of Basel, Switzerland (EKBB: 08/11) and 
conducted in accordance with the principles of the Declaration of Helsinki. All experimental procedures were 
carried out in accordance with the approved guidelines. All participants gave written informed consent prior to 
inclusion. Twenty-three (23) subjects were recruited through local and Internet advertising. Each participant 
underwent a medical interview, laboratory screening and gave written informed consent. Exclusion criteria were: 
lactose intolerance, smoking, substance abuse, regular intake of medications, medical or psychiatric illness, and 
any contraindication to MRI (e.g. claustrophobia, non-removable metal devices) or abnormalities detected upon 
laboratory screening. Of the 23 subjects originally recruited, three had to be excluded, as they did not meet the 
eligibility criteria. The final sample included 20 healthy volunteers (28.1 ± 6.2 years, 11 females). Estimation of 
statistical power in functional MRI requires knowledge of the expected percent signal change between two con-
ditions, as well as estimates of the variability in percent signal change. We calculated the sample size for a strict 
statistical adjusted threshold of p < 0.05, 20 subjects were required to achieve 50% power at the single voxel level 
for brain activations in the a priori defined networks of interest.
Experimental Protocol. This was a randomized, placebo-controlled, double blind, crossover study and was 
carried out at the Phase I Research Unit of the University Hospital of Basel. L-tryptophan, L-leucine, glucose 
and placebo were administered to each subject on four different days, following the procedure described below. 
The treatment order was randomized and at least 7 days passed between the visits. Therefore no interaction was 
present between the four administrations.
The subjects started each physiological and imaging examination between 9 and 10am in the morning, after an 
overnight fast of at least 10 hours. The subjects consumed no breakfast before the visits.
The study was carried out in three phases: Baseline (Time0), treatment administration (Time1) treatment 
assessment (Time2) (Fig. 4).
Before each visit health status assessment was performed orally by a physician. At the beginning of the experi-
ment an 8F polyvinyl nasogastric tube was inserted into the stomach through an anesthetized nostril and its intra-
gastric position was confirmed by rapid injection of 10 ml of air and auscultation of the upper abdomen. Then 
two blood samples were taken through a peripheral venous cannula and stored for laboratory analyses. Baseline 
examination (Time0) was then conducted, in order to control for possible differences in hormone levels and 
brain functions and structures before treatment administration. To assess for possible functional and structural 
differences at the brain level, subjects underwent an fMRI examination, including a functional resting state (RS) 
sequence and a T1 sequence. Before scanning a pillow in dotation of the MRI PRISMA was set in the head-coil 
behind the head of the subjects to prevent subjects head movements.
After the fMRI examination, the treatment was administered (Time1). The solutions were freshly prepared 
and were at room temperature when administered. L-tryptophan and L-leucine were purchased from Sigma 
Aldrich Chemical Company, Germany (> 97% pure) and glucose monohydrate was purchased from Haenseler 
AG (Herisau, Switzerland). Different persons prepared and administered the treatment, in order to maintain the 
double blindness of the study. Subjects received 300 ml tap water with 1.56 g (7.5 mmol) L-tryptophan, 1.56 g 
(11.89 mmol) L-leucine, 75 g glucose, and 300 ml pure tap water (placebo) via a nasogastric tube, over 2 minutes 
while sitting in the MR room.
15 minutes after administration, the tube was removed. To evaluate treatment effects, the subjects underwent 
a second physiological and brain imaging examination (Time2): blood sampling assessed through a peripheral 
venous cannula and fMRI examination (RS sequence) was repeated. No T1 sequence was used in this phase, since 
structural changes were not expected, due to the short period of time after treatment administration.
Laboratory analyses. Plasma glucose concentration was measured by a glucose oxidase method (Rothen 
Medizinische Laboratorien AG, Basel, Switzerland). The intra- and inter-assay coefficients of variation are below 
2.9% and below 3.9%, respectively.
Plasma Insulin was measured with a commercially available electrochemiluminescence immunoassay (Cobas/
Roche Diagnostics GmbH, Mannheim, Germany). The intra- and inter-assay coefficients of variation for this 
assay are below 2.0% and below 2.8%, respectively.
fMRI acquisition. Images were obtained using a 3T scanner (Prisma; Siemens, Erlangen, Germany) with a 
standard 32-channel head-coil. fMRI imaging of the whole brain was acquired by echo planar imaging, using the 
following parameters: whole brain coverage, TR = 1.8 s, TE = 28 ms, 35 slices, slice thickness 3.5 mm, 168 repe-
titions. The 3D T1-weighted structural scan had the following parameters: 256 × 256 matrix size, 176 sections, 
1 × 1 × 1 mm3, TE = 3.37 ms, TR = 2000 ms).
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Statistical Analysis. The statistical analyses were conducted using GraphPad Prism (Version 6, GraphPad 
Software, San Diego, USA), FSL (Version 5.0.9, FMRIB, Oxford, UK) and R (Version 0.99.896, The R-Project for 
Statistical Computing).
Analysis of physiological data. To compare hormones levels between the different treatments at Time1 
and Time2 separately, a repeated measure analysis of variance (ANOVA) was performed with Tukey correc-
tion for post-hoc pair-wise comparisons. Cohen’s effect size was also calculated using compute.es package in 
R (https://cran.r-project.org/) to assess the strength of the difference in hormones plasma levels between the 
treatments.
Functional connectivity analysis. Pre-processing of functional data. Processing and analysis of imaging 
data of Time1 and Time2 were performed using FSL. Preprocessing included brain extraction using FSL’s BET 
(Brain Extraction Tool), motion correction using FSL’s MCFLIRT (intra-modal motion correction tool)35, spatial 
smoothing of 5 mm using FSL’s SUSAN (noise reduction uses nonlinear filtering)36. High-pass temporal filtering 
of 100 seconds was used according to the standard MELODIC ICA procedure in FSL (http://fsl.fmrib.ox.ac.uk/
fsl/fslwiki/MELODIC). Functional images were first co-registered to structural images (acquired during Time1) 
using linear transformation and later normalized to MNI space using linear transformation. In addition, for each 
subject, we computed a maximum of the framewise displacement37,38 from the realignment parameters and sub-
jected this to group (treatments) comparison (ANOVA).
RSNs and Subcortical structures identification. To define brain networks at rest, independent com-
ponent analysis (ICA) was carried out on the resting state data of Time1 using FSL’s multi-session multivariate 
exploratory linear optimized decomposition into independent components (MELODIC Multi-session temporal 
concatenation)39. First automatic estimation of components was used to explore resting state networks, but due 
to high parcellation of the signal, the number of components was set to 25 as suggested by previous studies and 
as common practice in ICA for fMRI data40. Out of these 25 components, we decided to select and focus our 
analyses on 3 resting-state networks (RSNs) identified as consistent by previous studies41,42 and involved in appe-
tite regulation and control of metabolism43: Default Mode Network (DMN), Sensorimotor Network (SMN) and 
Saliency Network (SN).
RSNs group comparison and correlations with clinical scores. A dual regression approach with non-
parametric permutation (5000) tests (randomize, FSL) was carried out on the resting state data at Time1 and 
Figure 4. Study design. After an overnight stay of at least 10 hours, the study was carried out in three phases: 
Baseline (Time0), treatment administration (Time1) treatment assessment (Time2). The baseline examination 
(Time0) was conducted to control for possible differences in hormone levels and brain functions and structures 
before treatment administration. Two blood samples were taken through a peripheral venous cannula and 
stored for laboratory analyses (for blood collection method refer to 38. To assess for possible functional and 
structural differences at the brain level, the subjects underwent an fMRI examination, including a functional 
resting state (RS) sequence and a T1 sequence. After the fMRI examination, the treatment was administered 
(Time1). An 8F polyvinyl nasogastric tube was inserted into the stomach through an anaesthetized nostril. 
Subjects received 300 ml tap water with 1.56 g (7.5 mmol) L-tryptophan, 75 g glucose, 1.56 g (11.89 mmol) 
L-leucine and 300 ml pure tap water (placebo) via the nasogastric tube over 2 minutes while sitting in the 
MR room. 15 minutes after administration, the tube was removed. To evaluate treatment effects, the subjects 
underwent a second physiological and brain imaging examination (Time2): blood sampling assessed through 
a peripheral venous cannula and fMRI examination (RS sequences) were repeated. No T1 sequence was 
used in this phase, since structural changes were not expected in the short period of time after treatment 
administration.
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separately at Time2 to detect statistically significant differences between treatments (placebo vs. L-tryptophan, 
L-tryptophan vs. glucose, glucose vs. L-leucine, etc.) within the boundaries of the three RSNs identified at Time1. 
A repeated measure ANOVA was performed.
Results were corrected for multiple comparisons using threshold free cluster enhancement (TFCE) and p 
values < 0.05 were considered as significant. TFCE is similar to cluster-based thresholding, but generally more 
robust and avoids the need for the arbitrary initial cluster-forming threshold. It is recommended when randomize 
is performed44. Moreover, we performed an ANOVA comparing the visits in respect to time to test whether any 
interaction effect between times and treatments is present. Finally, Cohen’s effect size was also calculated for each 
comparison within each network using compute.es package in R (https://cran.r-project.org/).
Correlations between imaging and physiological results. Additionally, we tested for possible correla-
tions between regions that were significantly active in the previous contrasts and hormones levels.
On the basis of the results of the dual regression, we defined regional masks and extracted region-averaged 
time courses of each subject for the three resting state networks. These values were then correlated with the insu-
lin and glucose levels of each subject, using Pearson correlations.
VBM Analysis of T1 Images. To assess differences in grey matter density between groups, a voxel-based 
morphometric (VBM) analysis was performed in FSL (FSL Version 5.0.9; http://fsl.fmrib.ox.ac.uk), using stand-
ard processing steps45,46. Firstly, BET extraction and tissue-type segmentation were performed using the cor-
responding FSL tools (Brain Extraction Tool and FAST4). Secondly, non-linear transformation into Montreal 
Neurological Institute (MNI) reference space was applied and a study-specific grey matter (GM) template was cre-
ated. The native GM images were then non-linearly registered to this template. Finally, the images were smoothed 
with an isotropic Gaussian kernel of 2 mm sigma. A voxel-wise GLM was implemented using permutation-based 
nonparametric testing (Randomise, part of FSL). Results were corrected for multiple comparisons using TFCE44 
and p values < 0.05 were considered as significant.
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The present randomized double-blinded cross-over study aims to extensively study the 
neural correlates underpinning cognitive functions in healthy subjects after acute glucose 
and fructose administration, using an integrative multimodal neuroimaging approach. Five 
minutes after glucose, fructose, or placebo administration through a nasogastric tube, 
12 participants underwent 3 complementary neuroimaging techniques: 2 task-based 
functional magnetic resonance imaging (fMRI) sequences to assess working memory 
(N-back) and response inhibition (Go/No-Go) and one resting state fMRI sequence to 
address the cognition-related fronto-parietal network (FPN) and salience network (SN). 
During working memory processing, glucose intake decreased activation in the anterior 
cingulate cortex (ACC) relative to placebo, while fructose decreased activation in the 
ACC and sensory cortex relative to placebo and glucose. During response inhibition, 
glucose and fructose decreased activation in the ACC, insula and visual cortex relative to 
placebo. Resting state fMRI indicated increased global connectivity strength of the FPN 
and the SN during glucose and fructose intake. The results demonstrate that glucose 
and fructose lead to partially different partially overlapping changes in regional brain 
activities that underpin cognitive performance in different tasks.
Keywords: functional magnetic resonance imaging, glucose, fructose, brain–gut, working memory, cognition
inTrODUcTiOn
The mammalian brain depends upon sugars as the main source of energy, and the regulation of sugar 
metabolism is critical for brain physiology (1). Glucose and fructose, two of the most important 
monosaccharides, have a roughly equal number of calories but are metabolized differently (2). 
Glucose, a highly potent secretagogue, leads to the release of insulin and satiation hormones such as 
GLP-1 by enteroendocrine cells as well as inhibition of the appetite inducer ghrelin (3, 4). In contrast, 
fructose intake does not affect the release of insulin to the same extent (5, 6) and chronic fructose 
consumption may adversely affect human health by leading to increased de novo lipogenesis in the 
liver, hyperuricemia, and obesity (7, 8).
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The differences in the metabolism of glucose and fructose may 
also explain their differential effects on neuronal pathways. Page’s 
milestone study (9) has documented reduced relative cerebral 
blood flow and increased functional connectivity after the inges-
tion of sugars (both glucose and fructose) in the insula, anterior 
cingulate, striatum, and posterior cingulate cortex (appetite and 
food-reward regions). The effects from fructose were greater, and 
this resulted in increased brain activation in the visual cortex 
during a food-cue task (2). Similar results were found by a recent 
study conducted by our group investigating resting state func-
tional connectivity in the basal ganglia network (4).
Whereas changes linked to appetite stimulation in the human 
brain are generally accepted (2, 9, 10), recent animal studies sug-
gest that sugars may have different effects on brain regional activ-
ity underlying cognitive functioning (11–14). While extensive 
evidence indicates that increased glucose concentrations enhance 
learning and memory processes in rodents through the enhance-
ment of hippocampal activity (15), recent studies indicate that 
the hippocampus may be particularly vulnerable to the effects 
of fructose, with impaired synaptic plasticity and consequent 
decreased working memory performance after high-fructose 
diets (16, 17). To our knowledge, no previous studies have inves-
tigated the effects of glucose and fructose on whole-brain activity 
during different cognitive functions in humans.
Therefore, while dietary energy intake, in particular the con-
sumption of simple sugars such as fructose, has been increasing 
steadily in Western societies, the effects of such a diet on the 
human brain are still poorly understood (17). In particular, food 
intake (as sugars) can have a significant role beside age and gen-
der in multimodal neuroimaging studies (18). The present study 
can be considered as a starting point for future investigations also 
outside the brain-gut field, suggesting to assess nutrients intake 
in the functional magnetic resonance imaging (fMRI) analyses.
In the present study, we employ a functional multimodal 
approach to study the effects of glucose and fructose on differ-
ent cognitive functions. We administered glucose and fructose 
to the participants through a nasogastric tube inserted into the 
stomach. After 5 min, the participants underwent an extensive 
fMRI examination, performing one N-back task (to assess work-
ing memory), one Go/No-go task (to assess response inhibition), 
and one resting state sequence focusing on two cognition-related 
resting state networks, in particular the fronto-parietal network 
(FPN) and salience network (SN).
As glucose and fructose are subject to differential metabolic 
processes at the cellular level (2), we hypothesized that these 
monosaccharides would also induce dissociable effects on brain 
regional activity during cognitive functioning.
MaTerials anD MeThODs
Participants
The protocol was approved by the Ethics Committee of Basel, 
Switzerland (EKBB: 08/11) and conducted in accordance with 
the principles of the Declaration of Helsinki. All experimental 
procedures were carried out in accordance with the approved 
guidelines. The participants and the experiment protocol for the 
present study were already presented in a previous work of the 
same team (4). Fourteen (14) subjects were recruited through 
local and internet advertising. Each participant underwent a 
medical interview and laboratory screening and gave written 
informed consent prior to inclusion. Exclusion criteria were: 
lactose intolerance, smoking, substance abuse, regular intake of 
medications, medical or psychiatric illness, and any contraindica-
tion to MRI (e.g., claustrophobia, non-removable metal devices) 
or abnormalities detected upon laboratory screening. Of the 14 
(14) subjects originally recruited, 2 had to be excluded as they 
did not meet the eligibility criteria. There was also one drop-out, 
who was replaced. The final sample included 12 healthy volun-
teers (mean age: 24.8 years, range: 21–31 years, and mean BMI: 
22.9 kg/m2, range: 21.0–24.0 kg/m2).
experimental Protocol
This was a randomized, double-blind, cross-over study and was 
carried out at the Phase I Research Unit of the University Hospital 
of Basel. Glucose, fructose, and a placebo were administered to 
each subject on three different days, following the procedure 
described below. The treatment order was randomized and at 
least 7 days passed between the visits.
After an overnight fast of at least 10  h, an 8  F polyvinyl 
nasogastric tube was inserted into the subjects’ stomach through 
an anesthetized nostril and its intragastric position was verified 
by rapid injection of 10  ml air and auscultation of the upper 
abdomen.
The solutions were freshly prepared and were at room tem-
perature when administered. Glucose monohydrate and fructose 
were purchased from Hänseler AG (Herisau, Switzerland). 
Different persons prepared and administered the solutions. Over 
2 min, subjects received 300 ml of tap water with 75 g of glucose 
or with 25 g of fructose, or 300 ml pure tap water (placebo) via the 
nasogastric tube while sitting in the MR room. The administered 
doses were chosen on the basis of previous studies demonstrating 
lipogenesis increased in proportion after sugar intake (19).
Directly after administration, the tube was removed. To 
evaluate the treatment effect, the subjects underwent a brain 
imaging examination, including: three echo planar imaging 
(EPI) sequences (N-back task, Go/No-go task, and resting state 
sequence) and one T1 sequence.
fMri acquisition
Scanning was performed on a 3T scanner (Siemens Magnetom 
Verio). The N-back task sequence was performed using an EPI 
sequence (TR = 2,500 ms, TE = 28 ms, flip angle = 83°, field of 
view = 228 mm × 228 mm, 32 slices, slice thickness: 3 mm; voxel 
size = 3.6 mm × 3.6 mm × 3.3 mm). In total, 126 EPI volumes were 
acquired. The Go/No-Go task sequence was performed using an 
EPI sequence (TR = 2,500 ms, TE = 28 ms, flip angle = 83°, field of 
view = 228 mm × 228 mm, 32 slices, slice thickness: 3 mm; voxel 
size = 3.6 mm × 3.6 mm × 3.3 mm). In total, 160 EPI volumes 
were acquired. The resting state EPI sequence had the following 
parameters: TR = 2,000 ms, TE = 28 ms, flip angle = 82°, field 
of view = 228 mm × 228 mm, 32 slices, slice thickness: 3.3 mm; 
voxel size = 3.6 mm × 3.6 mm × 3.3 mm. In total, 152 EPI vol-
umes were acquired. Finally, the 3D T1-weighted structural scan 
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had the following parameters: 256 × 256 matrix size, 176 sections, 
1 mm × 1 mm × 1 mm TE = 3.37 ms, TR = 2,000 ms.
n-Back Task
During the N-back task (20–22), all participants saw series of 
letters with an interstimulus interval (ISI) of 2  s. Each stimu-
lus was shown for 1  s. During a baseline (0-back) condition, 
participants were required to press the button with the right 
hand when the letter “X” appeared. During 1-back and 2-back 
conditions, participants were instructed to press the button if the 
currently presented letter was the same as that presented in one 
(1-back condition) or two trials previously (2-back condition). 
The three conditions were presented in 10 alternating 30-s blocks 
(2 × 1-back, 3 × 2-back, and 5 × 0-back), matched for the num-
ber of target letters per block (i.e., 2 or 3), in a pseudorandom 
order. Task performance was expressed by the accuracy (number 
of correct responses to the 2-back task). A repeated measure of 
analysis of variance (ANOVA) was performed across the three 
visits.
go/no-go Task
After the N-back task, all patients immediately underwent an 
event-related Go/No-Go fMRI paradigm that was conducted 
with jittered ISIs and containing infrequently presented oddball 
stimuli to optimize statistical efficiency. This is a well-validated 
paradigm (23, 24), requiring either the execution or the inhibi-
tion of a motor response, depending on the visual presentation of 
the stimuli. The basic Go task is a choice reaction time paradigm, 
in which arrows point either to the left or to the right for 500 ms, 
with a mean ISI of 1,800 ms (jitter range: 1,600–2,000 ms). During 
Go trials, subjects were instructed to press the left or the right 
response button according to the direction of the arrow. In 11% 
of the trials, arrows pointing upward appeared. During these so-
called “No–Go” trials, participants were required to inhibit their 
motor response. During another 11% of the trials, arrows point-
ing left or right at a 23° angle were shown, and the subjects were 
told to respond in the same way as to Go stimuli (even though 
they pointed obliquely). These “oddball” stimuli were used as a 
control of the novelty effects associated with the low frequency 
and different orientation of the No–Go relative to the Go trials 
(stimulus-driven attention allocation). In total, there were 24 
No–Go, 160 Go, and 24 oddball trials, with task durations of 
approximately 6 min.
statistical analysis software
The statistical analyses were conducted using GraphPad Prism 
(Version 6, GraphPad Software, San Diego, CA, USA) and FSL 
(Version 5.0.9, FMRIB, Oxford, UK).
analysis of cognitive Performance
N-Back Task
To compare the performance during the N-back task, the reac-
tion time and the number of correct answers (accuracy) were 
investigated for all conditions. A repeated measure ANOVA 
was performed with Tukey correction for post  hoc pair-wise 
comparisons.
Go/No-Go Task
To compare the performance during the Go/No-go task, the 
reaction time and the “probability of inhibition” (ratio between 
No-Go correct and incorrect response) were investigated for all 
conditions. A repeated measure ANOVA was performed with 
Tukey correction for post hoc pair-wise comparisons.
Task-Based Functional imaging analyses
Pre-Processing
Processing and analysis of imaging data were performed using 
FSL FEAT (fMRI Expert Analysis Tool version 6.00, http://fsl.
fmrib.ox.ac.uk/fsl/fslwiki/FEAT). Pre-processing included brain 
extraction using FSL’s brain extraction tool, motion correction 
using FSL’s MCFLIRT (intra-modal motion correction tool) (25) 
and smoothing using FSL’s SUSAN (noise reduction uses non-
linear filtering) (26). Images were finally normalized to MNI 
space.
N-Back Task
After pre-processing, the linear-model analysis of the N-back 
sequence included two levels. At the first level, the contrast 
“2-back vs. 0-back” was calculated separately for each participant. 
At the second level, group differences between glucose, fructose, 
and placebo were investigated. This resulted in a mixed-effects 
group model implementing FLAME 1 (FMRIB’s Local Analysis 
of Mixed Effects). Finally, a repeated measures permutation-
based non-parametric test (randomize, FSL tool) was applied, 
correcting for multiple comparisons by threshold-free cluster 
enhancement (27). p-Values <0.05 were considered as significant.
Go/No-Go Task
After pre-processing, general linear models (GLM) analysis were 
performed to investigate brain activation differences during 
the Go/No-go sequence. At the first level, the contrast “No-go 
vs. oddball” was calculated separately for each participant. At 
the second level, group differences between glucose, fructose, 
and placebo were investigated. As above, a repeated measures 
permutation-based non-parametric approach (randomized, 
FSL tool) was applied, correcting for multiple comparisons by 
threshold-free cluster enhancement (27). p-Values <0.05 were 
considered as significant.
Functional resting state connectivity 
analysis
Resting State Network Identification
After pre-processing, to define brain networks at rest, an 
independent component analysis (ICA) was carried out on the 
resting state data using FSL’s multi-session multivariate explora-
tory linear optimized partition into independent components 
(MELODIC multi-session temporal concatenation) (28), setting 
the number of components to 20, which is common practice in 
ICA for fMRI data. Out of these 20 components, we decided to 
select and focus our analyses on 2 resting state networks (RSN): 
the fronto-parietal (also called executive functions) (FPN) 
network and the SN—identified as consistent with our previous 
studies (29, 30)—due to their involvement in cognitive functions 
TaBle 1 | Cross-modality correlations.
n-back go/no-go FPn sn
N-back 0.048 −0.316* −0.341*
Go/No-go 0.048 −0.465* −0.333*
FPN −0.316* −0.465* −0.383*
SN −0.341* −0.333* −0.383*
After performing task-based and resting state analyses, we carried out cross-modalities 
correlations analyses. Significant correlations were found between the N-back results 
and resting state connectivity strength, both for the FPN (p < 0.05) and salience 
network (SN) (p < 0.05). For the SN, significant correlations were found between the 
Go/No-go results and the resting state connectivity values (p < 0.05). The results are 
corrected for FDR multiple comparison corrections. Pearson R values are displayed. 
Significant levels are reported using the conventional*.
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and cognitive control (31–33). Cross-correlation of the two time-
series, timepoint by timepoint, using as reference RS maps of 
Laird (30) were performed to compare the EF and SN networks 
to a major RSN template using a higher number of subjects.
RSNs Group Comparison
A dual regression approach (34) was carried out on the resting 
state data within the boundaries of the identified RSN. Region-
averaged time courses of each subject for the three resting state 
networks were extracted and submitted to a repeated measure 
ANOVA to test for differences between the treatments, using 
Tukey correction for post hoc pair-wise comparisons.
cross-Modalities correlations
After the task-based and resting state studies, we performed 
cross-modalities correlations analyses.
The regional averaged time-course was extracted across the 
subjects for the N-back and the Go/No-go for the significant 
contrasts. Moreover, connectivity values from the identified 
component for the resting state analyses were used. Individual 
correlation analyses across modalities were performed. FDR 
multiple comparisons corrections were used (Table 1).
resUlTs
Behavioral results
N-Back Task
The ANOVA showed no significant differences in accuracy across 
treatments.
Go/No-Go Task
No significant treatment differences were found for the prob-
ability of inhibition.
n-Back activations
Absolute values for motion are (mean ± SD): glucose 0.14 ± 0.04, 
fructose 0.17 ± 0.05, placebo 0.12 ± 0.04. Relative values for motion 
are (mean ±  SD): glucose 0.04 ±  0.01, fructose 0.046 ±  0.01, 
placebo 0.042 ± 0.01.
In the task-related GLM, we considered the contrast of 
“2-back versus 0-back.” Relative to placebo, glucose significantly 
reduced activation in the anterior cingulate cortex (ACC)/dorsal 
pre-frontal cortex (Figure  1A; Table S1A in Supplementary 
Material). Relative to placebo, fructose significantly reduced 
activation in the ACC/dorsal pre-frontal cortex, sensory cor-
tex, and cerebellum (Figure  1B; Table S1B in Supplementary 
Material). Glucose compared with fructose also significantly 
increased activation in the bilateral dorsal pre-frontal cortex 
and cerebellum (Figure  1C; Table S1C in Supplementary 
Material).
go/no-go activations
Absolute values for motion are (mean ± SD): glucose 0.16 ± 0.06, 
fructose 0.21 ±  0.07, placebo 0.17 ±  0.07. Relative values for 
motion are (mean ± SD): glucose 0.04 ± 0.01, fructose 0.04 ± 0.01, 
placebo 0.04 ± 0.01.
Relative to placebo, glucose significantly reduced activation 
in the ACC, dorsal pre-frontal cortex, right insula, and visual 
cortex (Figure  2A; Table S2A in Supplementary Material). 
Relative to placebo, fructose significantly reduced activation in 
the ACC, dorsal pre-frontal cortex, sensory cortex, and visual 
cortex (Figure  2B; Table S2B in Supplementary Material). 
No significant differences were found between glucose and 
fructose.
Functional resting state connectivity 
analysis results
Absolute values for motion are (mean ± SD): glucose 0.14 ± 0.03, 
fructose 0.17 ±  0.05, placebo 0.15 ±  0.04. Relative values for 
motion are (mean ± SD): glucose 0.06 ± 0.02, fructose 0.07 ± 0.02, 
placebo 0.06 ± 0.02.
Group analyses of frame wise displacement found no 
significant effect of motion between the visits. Cross value 
correlations are for the EF network: r =  0.3, p <  0.01 and for 
the SN r = 0.4, p < 0.01. Repeated measure ANOVA revealed a 
significant main effect in functional connectivity in the fronto-
parietal network (FPN) network [F(2, 11) = 13.69, p < 0.001] 
(Figure  3A). Subsequent post  hoc testing showed significantly 
higher connectivity strength after ingesting glucose than with 
placebo (p < 0.05) or fructose (p < 0.05), while an increase in 
connectivity in the FPN network was found after fructose inges-
tion compared with placebo (p  <  0.01). Moreover, repeated 
measure ANOVA also revealed a significant main effect of 
treatment in functional connectivity in the SN network [F(2, 
11) = 6.117, p < 0.05] (Figure 3B). In particular, significantly 
higher connectivity strength than with placebo was found after 
ingesting glucose (p < 0.05) or fructose (p < 0.05). No differ-
ences in connectivity were found between glucose and fructose 
ingestion.
cross-Modalities correlations results
Significant correlations were found between the N-back results 
(p <  0.05) and resting state connectivity values, both for FPN 
(p < 0.05) and SN (p < 0.05). For the SN, significant correlations 
were found (p < 0.05) between the Go/-No-Go results and the 
resting state connectivity values. The results are corrected for 
false discovery rate multiple comparison corrections. Results are 
displayed in Table 1.
FigUre 1 | N-back functional imaging results. In the task-related general linear models, we considered the contrast of “2-back versus 0-back.” The comparison 
“glucose vs. placebo” revealed significantly reduced activation after ingesting glucose in the anterior cingulate cortex (ACC)/dorsal pre-frontal cortex [(a), Table S1A 
in Supplementary Material]. The comparison “fructose vs. placebo” revealed significantly lower activations after ingesting fructose, particularly in the ACC/dorsal 
pre-frontal cortex, sensory cortex, and cerebellum [(B), Table S1B in Supplementary Material]. The comparison “fructose vs. glucose” revealed significantly greater 
activations after ingesting fructose in the bilateral dorsal pre-frontal cortex and cerebellum [(c), Table S1C in Supplementary Material]. Z-stat values are shown in the 
color bar. The results are given by repeated measures permutation-based non-parametric test (randomize, FSL tool) approach, correcting for multiple comparisons 
by threshold-free cluster enhancement (27). p-Values <0.05 were considered as significant.
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DiscUssiOn
The present study performs an extensive assessment of cognition-
related brain functional changes after glucose and fructose 
administration. Although we found no significant differences 
in behavioral performance during working memory processing 
and response inhibition, both glucose and fructose decreased 
activation in frontal areas such as the ACC and dorso-lateral 
pre-frontal cortex (DLPFC) during working memory processing 
and response inhibition—especially after fructose intake. The 
connectivity of these regions as parts of the FPN and SN is in 
turn increased during glucose and fructose ingestion.
Our first group of results relate to the absence of differences 
in task performance during working memory processing and 
response inhibition after glucose and fructose intake compared 
with placebo. The absence of changes in performance after fructose 
intake is confirmed by animal studies that found no differences in 
cognitive/motor performance as measured by object recognition 
FigUre 2 | Go/No-go functional imaging results. In the task-related general linear models, we considered the contrast of “No-go versus Oddball.” The comparison 
“glucose vs. placebo” revealed significantly reduced activations after ingesting glucose, particularly in the anterior cingulate cortex (ACC), the dorsal pre-frontal 
cortex, right insula, and visual cortex (a). The comparison “fructose vs. placebo” revealed significantly lower activations after ingesting fructose in the ACC, the 
dorsal pre-frontal cortex, sensor cortex, and visual cortex (B). No significant differences were found for the comparison glucose vs. fructose. Z-stat values are 
shown in the color bar. The results are given by repeated measures permutation-based non-parametric test (randomize, FSL tool) approach, correcting for multiple 
comparisons by threshold-free cluster enhancement (27). p-Values <0.05 were considered as significant.
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and fear conditioning in rodents (35, 36) and by a recent review 
(11) that concluded that fructose does not induce cognitive 
deficits. Published reports on behavioral differences after glucose 
administration are inconsistent with respect. Although a previ-
ous study (37, 38) reported improvements in object recognition 
and word-recall performance after glucose intake, other authors 
have found no differences in cognitive performance (39–41). 
In the present study, we confirm the absence of changes at the 
behavioral level after sugar administration. From our perspec-
tive, this is still an open field of research and our results with 
this small sample size are not definitive. Although fMRI data 
on small subject numbers are relatively robust (42), behavioral 
indexes are typically underpowered and could be confounded by 
many personal attributes that cannot be clearly assigned to the 
cognition required for adequate task performance (43).
Our second group of results relate to changes at the level of 
brain function. During working memory processing, decreased 
activation in the ACC and DPFC was shown after glucose admin-
istration. Less activation in the ACC/DPFC and in the sensory 
cortex was found after fructose administration than after glucose 
administration.
As previous studies on cognitive functions and induced-train-
ing suggested, decreased brain activation during a demanding 
cognitive load is associated with more efforts to perform a task 
(44–47). According to this interpretation, our results suggest 
the subjects show less demanding brain activation during the 
stimulus-response association task after glucose and fructose 
intake than with placebo (48, 49). Moreover, our findings are 
in line with a recent study that concluded that after glucose and 
fructose intake the participants showed significantly decreased 
cerebro-spinal fluid relative to placebo, particularly in the ACC, 
insula, and thalamus compared with Ref. (9).
In comparison with placebo, we found reduced functional 
activation in the ACC, DPFC, insula, DLPFC, and visual cortex 
after glucose and fructose administration. No differences between 
glucose and fructose were found, which was comparable with the 
results during working memory processing.
Although working memory involves temporary storage and 
manipulation of the information (50) and response inhibition 
involves the suppression of actions that are no longer required 
or inappropriate (51), our results indicate that acute glucose and 
fructose administration similarly modulates brain activation dur-
ing these two cognitive processes.
Our third group of findings relates to differences in resting 
state functional connectivity after fructose and glucose intake. 
The connectivity within the FPN and the SN is increased during 
FigUre 3 | Independent component analyses results. After dual regression on the executive functions network (EF) and extracting the connectivity strength values, 
repeated measure analysis of variance (ANOVA) revealed significant activation in the EC network for the three groups (a). In particular, significantly higher 
connectivity strength was found after ingesting glucose than with placebo (p < 0.01) and fructose (p < 0.01), while an increase in connectivity was found in the EC 
network after fructose ingestion (p < 0.05) compared with placebo. Moreover, repeated measure ANOVA revealed significant differences in functional connectivity in 
the salience network too for the three groups (B). In particular, significantly higher connectivity strength was found after ingesting glucose than with placebo 
(p < 0.05) and fructose compared with placebo (p < 0.05). No differences in connectivity were found between glucose and fructose ingestion. Mean and standard 
errors are reported. Significant levels are reported using the conventional*. Z-stat values are shown in the color bar. The results are given by repeated measures 
permutation-based non-parametric test (randomize, FSL tool) approach, correcting for multiple comparisons by threshold-free cluster enhancement (27). p-Values 
<0.05 were considered as significant, **p < 0.01.
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both fructose and glucose intake compared with placebo; this 
is comparable with the task-induced fMRI findings, but in the 
opposite direction.
The increase in connectivity after glucose intake has already 
been reported several times (4, 9, 52, 53), but ours is the first study 
to demonstrate increased functional connectivity in networks 
related to cognitive functions after fructose intake.
Our correlation analyses confirm that glucose and fructose 
intake lead to increased functional connectivity in the FPN 
and SN and to decreased efforts during working memory and 
response inhibition tasks.
We finally want to mention, as already suggested in Section 
“Introduction,” that food intake may play a significant role beside 
age and gender in multimodal neuroimaging studies (18). The 
present work can be considered as a starting point for future 
investigations also outside the brain-gut field, suggesting to 
assess nutrient intake beside age, and gender changes on brain 
functional activity, using them for instance as covariates in the 
fMRI analyses.
limitations
Some limitations of our study merit comment. As in previous 
neuroimaging studies of the brain-gut axis in healthy subjects, our 
sample size was modest since it is intended to be a pilot study. In 
addition, the present study focused only on glucose and fructose, 
while sucrose and other substances could also be investigated. 
Our results might potentially be influenced by external factors 
such as daily mood variations not investigated by examination 
of the health status of the participants. However, it is important 
to point out/emphasize that the aim of the present study was 
to investigate changes in brain networks involved in cognitive 
functions and this was why emotional changes were not studied 
in detail. In the fMRI analyses, it is important to notice that 
smoothing may introduce spurious local functional connectivity 
and affect the subsequent conduction of ICA, but we decided to 
keep the smoothing in order to reduce noise. We also want to 
stress that while we randomized for the treatment assignment 
order, and for the sequence of stimuli during the tasks, we did 
not randomize for the fMRI sequences ordering. We therefore 
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suggest future investigations to randomize also for the fMRI tasks 
ordering, to control for ordering effects.
To conclude, the results of the present work suggest the pres-
ence of two partially overlapping neural pathways related to cog-
nitive functions after glucose and fructose ingestion. The working 
memory and the response inhibition pathways showed that glu-
cose and fructose decrease activation and increase connectivity 
strengths in regions in the FPN and the SN. These results are to be 
considered as part of a preliminary and exploratory investigation 
of sugar effects on cognitive functions. Our findings suggest that 
future studies on diet-induced manipulations are plausible and 
efficient for pathologies affecting the cognitive dimension.
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DISCUSSION 	  
The present PhD thesis aims at investigating the brain gut matrix. First, through a 
systematic review of the literature, previous studies assessing the effects of 
nutrients on brain functions were examined. A global picture on the relationship 
between the brain and the gut is therefore available and a common research 
methodology can be identified. 
Second, we performed a set of studies investigating the effects of sugars and 
amino acids on satiety hormones and RS functional networks involved in appetite 
regulation. 
Third, we investigated more specifically the effects of sugars beyond appetite 
and satiety, focusing on cognitive functions and discriminating their effects on 
working memory and response inhibition.  
These three studies therefore provide us with a general overview of the different 
processes occurring in the brain-gut interaction.  
 
The brain-gut matrix: a systematic review. 
To our knowledge, this is the first systematic review on the effects of gut peptides 
on brain functions in healthy and obese subjects. 349 studies were investigated 
and 40 were retrieved. 
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Due to the exploratory nature of the present review, it is important to highlight 
differences in the methodology between the studies.  
A first distinction is the gut-peptides stimulation. Half of the studies used a direct 
administration of the target substance, as insulin, and the other half an indirect 
administration of a nutrient, as chocolate milkshake, that indirectly stimulated gut 
peptides. This choice impacts as well the aim of the investigations, the first is 
specifically useful for the direct assessment of gut peptides effects on brain 
functions and the second for assessment of the nutrients effects on gut peptides 
(Malik et al, 2008).  
 
Moreover, differences in substance intake can also influence the procedure of 
data acquisition increasing the easiness for the participants (Zanchi et al, 2016), 
they can also lead to changes in the timing of nutrient absorption that can 
influence the fMRI paradigm (De Silva et al, 2012; Liu et al, 2000a; Malik et al, 
2008). While the majority of the studies used a “food-cue paradigm”, presenting 
high and low caloric food cues, few used what we called an ‘on-off treatment 
related block design’ by the timing of hormonal plasma absorption to investigate 
the brain response. Finally, a classical resting state paradigm was used for the 
remained works (Zanchi et al, 2017).  
 
Regarding neuroimaging results, ghrelin plasma concentration is positively 
associated with activity in areas part of the food-reward system as the Pre-frontal 
Cortex (PFC), amygdala and insula and negatively with activity in subcortical 
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areas as the hypothalamus. In contrast, satiety-regulating gut hormones or 
nutrients like glucose, insulin, letpin and GLP-1 affect the same brain regions in 
the opposite directions (Zanchi et al, 2017).  
The results we found reflect the model proposed by Woods, showing activation in 
frontal regions as the Orbito-Frontal Cortex (OFC), Anterior Cingulate Cortex  
(ACC) and insula associated positively to ghrelin plasma levels and with 
increased hunger feelings. Subcortical areas like the thalamus, hippocampus, 
striatum and hypothalamus correlated negatively with ghrelin levels (Woods et al, 
1998). 
As Woods stated, adipose signals (ghrelin and insulin) penetrate the blood brain 
barrier and stimulate receptors on neurons in the hypothalamus, amygdala and 
striatum (Woods et al, 1998) after food intake where they influence reflexes 
related to the acceptance or rejection of food. Afterwards, the hypothalamus 
signals cortical areas part of the reward mechanism as the OFC, ACC and 
insula, where higher cognitive process begins. At this point the eating behaviour 
is determined (Higgs et al, 2017).  
 
Effects of sugars and amino acids intake on brain resting state 
functional connectivity. 
Our first study aims at investigating the effects of sugars and amino acids on 
brain resting state networks related to satiety regulation. In particular, we chose 
three resting state functional networks involved in food-reward mechanisms: the 
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Default Mode Network (DMN), the Sensorimotor Network (SMN) and the 
Salience Network(SN) (De Silva et al, 2012).  
Our results reveal that sugars and amino acids intake show differential effects on 
RS functional connectivity. Specifically, tryptophan shows the highest increase in 
connectivity within the sensory-motor network in the somatosensory area, within 
the default mode network in the cingulate cortex and in the precuneus and within 
the salience network in the bilateral insula, when compared to placebo and 
glucose (Zanchi et al, 2016). The reorganization in the sensorimotor network is 
also present after glucose administration compared to placebo. The 
somatosensory area (SMA) is one of the main brain areas involved in appetite 
regulation, integrating sensory and visceral signals associated with protein intake 
(Liu et al, 2000a; Park et al, 2016, 2016). This is confirmed in our study by the 
positive correlation found between changes in activity in SMA and in insulin.  
 
Moreover, due to changes in the DMN and SN connectivity, we speculate that 
tryptophan and glucose also impact brain areas involved in a broad class of 
functions, beyond satiety regulation. In particular, several works confirm the 
involvement of the DMN in mood regulation (Sheline et al, 2009; Shi et al, 2015; 
Uchida et al, 2015) and of the SN in cognitive functions (Cao et al, 2016; Menon 
and Uddin, 2010; Putcha et al, 2016). Manipulation of serotonin levels associated 
to tryptophan intake leads to changes in the activity in prefrontal regions that in 
turn can affect cognitive control and emotion processing (Dantzer et al, 2011; 
Passamonti et al, 2012; Seymour et al, 2012; Williams et al, 2007). Tryptophan 
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depletion is also associated with decision making processes and depressive 
mood (Krämer et al, 2011; Kunisato et al, 2011). 
 
We finally want to highlight the role of L-leucine on brain network activity at rest. 
The comparison L-leucine vs. Placebo shows no significant differences. 
However, the visual differences between tryptophan and L-leucine when 
compared to water suggest that the effect of L-leucine on functional activity is not 
equivalent to the one of water. We believe that the absence of significant results 
is due to the modest sample size that decreases the statistical power. However, 
we can only speculate and we are not allowed to go further with our 
interpretation.  
Further investigations are needed to clarify the effect of this amino acid on brain 
networks at rest. 
 
Effects of sugars intake on brain activity underpinning cognitive 
functions. 
Our second study explores brain activity changes related to sugars 
administration beyond the food-reward mechanisms, investigating the impact of 
glucose and fructose on cognitive functions. In particular working memory, 
assessed by the N-back task, is a cognitive function involved in temporary 
storage and manipulation of the information necessary for complex cognitive 
tasks (Baddeley, 1992; Jacola et al, 2014; Owen et al, 2005).Response 
inhibition, assessed using Go/no-go task, is involved in the suppression of no-
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longer required or inappropriate actions, which supports flexible and goal-
directed behaviors (Simmonds et al, 2008; Verbruggen and Logan, 2008). 
 
Our first results show no differences in task performance during N-back and 
Go/no-go task tasks after glucose and fructose intake when compared to 
placebo. Although our results are confirmed by several previous studies (Beilharz 
et al, 2015), we believe that the small sample size does not allow an extensive 
investigation of the behavioral performance (Wilkinson and Halligan, 2004). 
Further studies with a bigger sample size are suggested to depict differences in 
performance also in light of our functional results. In fact, as several studies 
showed, the BOLD signal is more sensitive to tasks than the behavior (Balsters 
et al, 2013; Bonakdarpour et al, 2015). 
Our second results related to decreased activation in frontal areas, as the ACC 
and dorso-lateral pre-frontal cortex (DLPFC), during working memory processing 
and response inhibition after both glucose and fructose ingestion compared to 
placebo. The connectivity of these regions as parts of the Fronto-Parietal 
Network (FPN) and Saliency Network (SN) is in turn increased during glucose 
and fructose ingestion.  
As stated above, studies on cognitive functions and induced-training suggested 
decreased brain activation during a cognitive task is associated with more efforts 
to perform a task, while increased activation is associated with higher easiness to 
perform the task (Engström et al, 2013; Erickson et al, 2007; Heinzel et al, 2016; 
Lee et al, 2012). Following this interpretation, glucose and fructose administration 
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when compared to placebo facilitate the stimulus-response association and in 
turn lead to decreased activation in brain areas related to cognitive functions 
(Corbetta and Shulman, 2002; Erickson et al, 2005).  
Our correlation analyses confirm that glucose and fructose intake lead to 
increased functional connectivity in the FPN and SN and to decreased efforts 
during working memory and response inhibition tasks. 
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Limitations and further directions. 
Due to the exploratory nature of the present work, it is important to highlight the 
limitations of the investigated studies and suggest possible improvements for 
future works on the brain-gut interaction. 
First, we suggest to decrease the variability of the administered substances. 
Although it can appear as counterintuitive, this will decrease the complexity of the 
studies (less nutrients ingested will lead to a precise discrimination of their direct 
and indirect effects on gut peptides) promoting an univocal methodology in terms 
of nutrients intake and timing of administration (Sizonenko et al, 2013). 
This will also impact the easiness of the recruitment procedure increasing the 
sample size and therefore the statistical power, allowing to disentangle more 
consistent results in particular at the behavioral level. Decreasing the complexity 
of the studies and increasing the sample size is a straightforward improvement 
for the next generation of studies on the brain-gut interaction (Charan and 
Biswas, 2013). 
A third important improvement is the different paradigms and imaging analyses 
involved. Due to the exploratory nature, different paradigms were used. A 
validation of more specific instruments will disentangle more specifically the 
effects of nutrients administration on brain functions (Francis and Eldeghaidy, 
2015; Isaacs, 2013; Sizonenko et al, 2013).  
This point is also connected to the statistical analyses used to analyze brain 
data. A work on the methodology of fMRI analyses where changes to the 
classical General Linear Model (GLM) model are explored is essential. In 
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particular, using as regressors the “area under the curve” of plasma 
concentration of gut hormones will model the statistical analyses accordingly to 
pharmacodynamics and pharmacokinetics effects. The milestone study of Liu 
demonstrated already this possibility (Liu et al, 2000a). 
A further improvement would be the investigation of the impacts of the nutrients 
on brain activity beyond satiety regulation and cognitive functions, such as mood 
and emotional feelings, as previously suggested (Benton and Donohoe, 1999; 
Casper, 2004). As we demonstrated after sugars intake, nutrients can also 
impact large scale of neural functions. 
This is may also be related to the effects of release of gut hormones that are 
associated with pathological conditions, as suggested by previous studies this 
may be of particular interest in psychiatry, due to the alteration of neural 
functions as mood and reward mechanisms, involved in depression and anxiety 
(Jacka, 2017; Lakhan and Kirchgessner, 2013). Moving towards this speculation, 
the idea that a diet can lead to improvements to normalize psychiatric condition 
acting on specific brain areas is a further direction to be explored. 
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